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Stroke is the third leading cause of death in developed countries, after heart disease and 
cancer, and the first cause of disability.1 Most strokes are ischemic and caused by occlusion of 
a cerebral artery. This leads to dysfunction and eventually death of brain tissue through lack of 
oxygen. This results in typical symptoms such as unilateral weakness, language disturbances, 
unilateral sensory disturbances, hemianopia, ataxia, or impaired speech. In the acute phase of 
tissue dysfunction, patients can be treated with thrombolytic agents, but treatment should be 
started within 4,5 hours after onset of symptoms. However, at present, only 25% of patients are 
eligible for this treatment, and even when patients can be treated, treatment is not always suc-
cessful.2 In many patients, cerebral ischemia is only transient and does not result in persistent 
symptoms and disability. These Transient Ischemic Attacks (TIAs) or minor ischemic strokes 
offer the opportunity to prevent major, disabling strokes or other vascular events. Secondary 
prevention is therefore one of the main objectives of stroke management.
Risk of recurrent stroke is approximately 9-16% annually after ischemic stroke. Intensive 
secondary prevention by use of antiplatelet medication and treatment of high blood pressure 
and high cholesterol has reduced the annual risk of recurrent events to approximately 4.5%.3 
The most well-known risk factors for stroke or other major vascular events such as myocardial 
infarction or vascular death are age, male sex, hypertension, diabetes, and smoking. There are 
many other risk factors such as white matter lesions, carotid or vertebral artery stenosis, and 
atrial fibrillation. Unfortunately, even with this large number of prognostic factors, it is still hard 
to discriminate between patients with a high risk of recurrent stroke and patients with a low 
risk of recurrent stroke. It has therefore been contended that it is important to identify new risk 
factors for the occurrence of stroke and other major vascular events.4
Transcranial Doppler ultrasonography, the main topic of this thesis, offers noninvasive infor-
mation on flow velocity, cerebral CO2 reactivity, and the presence of micro-embolic signals. 
These three parameters may provide new predictors of increased risk of stroke recurrence and 
other vascular complications. Transcranial Doppler ultrasonography allows the noninvasive 
investigation of arterial blood flow within the skull.5 It was first described in 1982 by Aaslid et 
al.5 Low frequency (2 MHz) ultrasound can pass through the bone at the level of the temporal 
window, which is located just above the ear where the temporal bone is the thinnest. Pulsed 
wave ultrasound is reflected by flowing blood, which reflects the ultrasound wave. This causes 
a phase shift, wherein the frequency is decreased or increased, depending on which direction 
the blood is flowing. This frequency change correlates directly with the blood flow velocity. This 
is called the Doppler effect. With this technique several parameters can be studied in the main 
cerebral arteries: flow velocities (mean flow velocity, peak flow velocity, and end-diastolic flow 
velocity), cerebral CO2 reactivity, and micro-embolic signals (MES), which are described below.
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Flow velocity parameters
As the velocity in the major cerebral arteries is dependent on the heartbeatcycle, peaksys-
tolic flow velocity (PSV) and end-diastolic flow velocity (EDV) can be defined as parameters 
(Figure 1). With these parameters mean flow velocity (MFV) can be calculated:
MFV= EDV + 1/3(PSV-EDV).
Pulsatility index (PI), a measure of peripheral vascular resistance can be calculated as:
(PSV-EDV)/MFV
High flow velocity parameters are diagnostic for a middle cerebral artery (MCA) stenosis. A 
mean flow velocity of > 100 cm/s or a PSV of > 140 cm/s is highly suggestive of a MCA stenosis 
of more than 50%.6 A MCA stenosis is, however, rare in Caucasian patients.7,8 patients with a 
MCA stenosis of more than 50% have an increased risk of recurrent stroke compared to patients 
without a MCA stenosis. MFV in the MCA is related to age and sex. MFV decreases with age9 
and MFV is higher in women.10 The relationship with other vascular risk factors in unclear. In 
healthy elderly patients an increased MFV is related to increased risk of stroke.11 Before TCD 
parameters can be studied as diagnostic or prognostic factors, these relationships will have to 
be investigated.
cerebral co2-reactivity
The compliance of the cerebral circulation, also called the cerebral vasomotor reactivity or 
cerebral CO2-reactivity, can be measured.
12 The cerebral CO2-reactivity measures the flow 
velocity change in a major cerebral artery during hypercapnia. During hypercapnia distal 
vasodilatiation occurs and therefore the flow velocity in the observed major artery will have 
to rise. The cerebral CO2-reactivity is the percentage increase in flow velocity in the observed 
Figure 1: Example of TCD signal: Flow velocity in the left middle cerebral artery. On the X-axis is the 
timeline (in seconds), on the y-axis the flow velocity in cm/sec.
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major artery, usually the middle cerebral artery (Figure 2). This is thought to reflect the vascular 
reserve capacity in the brain.
Cerebral CO2-reactivity diminishes in patients with a severe carotid artery stenosis or occlu-
sion, and is a predictor of recurrent stroke in these patients.13,14 It is unknown whether this 
applies for patients without a carotid artery stenosis. An impaired cerebral CO2-reactivity is 
related to various vascular risk factors such as hyperlipidemia and diabetes, and to the presence 
of white matter lesions on MRI scan of the brain.15-17 In patients with a lacunar infarction, the 
cerebral CO2-reactivity is lower than in healthy controls.
18 This may suggest that an impaired 
cerebral CO2-reactivity is a prognostic factor for stroke. The cerebral CO2-reactivity seems to 
distinguish between patients with a cortical infarction and patients with a lacunar infarction,19 
but this has not been reproduced. The diagnostic and prognostic value of the cerebral CO2-
reactivity in patients without a carotid artery stenosis is therefore still unknown.
micro-embolic signals
With continuous TCD registration, circulating micro-embolic signals (MES) can be detected 
(figure 3). Due to increased scattering and reflection of ultrasound from the embolus, compared 
Figure 2: example of Cerebral CO2-reactivity.The x-axis represents the time line. The upper lines represent 
the flow velocities in the left (red line) and right (green line) middle cerebral arteries measured in cm/s 
(y-axis). The lower lines represent the end-tidal CO2 (blue line, and the actual expired CO2 concentration 
(red line). Note that flow velocities increase during hypercapnia and quickly return to normal during 
normal ventilation. The percentage increase in mean flow velocity during hypercapnia represents the 
cerebral CO2 reactivity.
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with the surrounding red blood cells, an embolus appears as a short duration high intensity 
signal within the Doppler flow spectrum.
MES occur more frequently in acute stroke patients with a history of TIA or ischemic stroke20 
and in patients with symptomatic or asymptomatic carotid stenosis.21-23 In these patients 
the presence of MES constitutes a higher stroke risk. Higher prevalence rates are reported in 
patients with atrial fibrillation compared to those without. Patients with a mechanical heart 
valve have more frequent and louder MESs than those with a biological valve.24-26 These MES 
are thougth to be gaseous, not solid.27 All together MES may be of importance in detecting 
potential sources of cardiac28 (or extracranial) embolism.
Furthermore, the presence of MES may play a role in differentiating between stroke sub-
types. In patients with lacunar infarction (small vessel disease) MES were observed less often 
than in patients with non-lacunar infarcts,which are often caused by cardiac embolism or large 
vessel disease.29
Feasibility of tcD investigation
TCD ultrasound is a noninvasive procedure. It takes approximately 30 minutes. The use of head-
bands and semi-automated MES detection greatly improves its applicability in clinical practise. 
In approximately 10 to 20% of the patients, no adequate Doppler signal can be obtained.30 It 
has been postulated that the thickness of the temporal window plays a crucial role here.
Aim of this thesis
The overall aim of my thesis is to investigate whether it is worthwile to perform a TCD investiga-
tion for diagnostic and prognostic purposes on all patients with a recent TIA or minor ischemic 
stroke.
Figure 3: Example of a TCD signal in the middle cerebral artery with a micro-embolic signal (white arrow)
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My research questions are:
1. Can TCD be of diagnostic value in detetecting the presence of a potential cardiac source of 
embolism and the presence of small vessel disease in patients with a TIA or minor ischemic 
stroke?
2. Is it possible to identify patients with a high risk of recurrent vascular events after TIA or 
minor ischemic stroke by means of TCD investigation?
Firstly, we assessed the diagnostic value of TCD in a large cohort of patients with a recent TIA 
or non-disabling ischemic stroke (Chapter 2.1). We therefore analysed the relationship of the 
above mentioned TCD parameters with vascular risk factors and evaluated the value of TCD in 
screening for a potential cardiac cause of embolism (PCSE) and for stroke subtype (Chapter 2.3). 
In Chapter 2.2 we describe which patients have a high risk of having window failure.
Secondly, we assessed the prognostic value of TCD in patients with a recent TIA or non-
disabling ischemic stroke. We therefore analysed the prognostic value of the different TCD 
parameters for a recurrent major vascular event (Chapter 3.2 and 3.3). We then validated several 
prediction models on the data from the present study (Chapter 3.1), and evaluated if these TCD 
parameters improved existing predicition models (Chapter 3.4).
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chapter 2.1
Relationships of transcranial blood flow Doppler 
parameters with major vascular risk factors: 
TCD study in patients with a recent TIA or non-
disabling ischemic stroke
A.D. Wijnhoud
P.J. Koudstaal
D.W.J. Dippel
J Clin Ultrasound. 2006 Feb;34:70-6
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AbstrAct
Purpose: The relationship between intracranial vascular disease and cardiovascular risk factors, 
such as smoking, hypertension, diabetes mellitus, and total serum cholesterol in patients with 
recent cerebral ischemia is not well-established. We used transcranial Doppler ultrasonography 
(TCD) tests as parameters of intracranial vascular disease, and investigated the relationship 
between these parameters and conventional cardiovascular risk factors.
Methods: We prospectively studied 598 patients with a minor ischemic stroke or TIA. In all 
patients, flow velocities in the left and right MCA, as well as the cerebrovascular CO2 reactivity 
were measured by means of TCD. Student’s t-test and linear regression analysis were used to 
determine the relationship between the baseline characteristics, vascular risk factors and TCD 
parameters.
Results: After adjustment for other vascular risk factors, a statistically significant relationship 
with mean flow velocity in the MCA was found for age (3.5 cm/s/10 yrs of age, 95% C.I.: 2.5 to 4.5 
cm/s/10yrs, p<0.0001), sex (-2.9 cm/s for male sex, 95% C.I.: -5.5 to -0.3 cm/s, p=0.03), diabetes 
(5.6 cm/s for diabetics, 95% C.I.: 2.1 to 9.1 cm/s, p=0.002), and total serum cholesterol (2.4 cm/s 
per mmol increase in total serum cholesterol, 95% C.I.:1.4 to 3.5 cm/s, p<0.0001). Total serum 
cholesterol and hypertension were related to cerebrovascular CO2 reactivity.
Conclusion: Cerebral flow velocity is influenced by multiple interacting factors. Results of TCD 
investigations will have to be adjusted for age, sex, diabetes, and cholesterol when they are 
used for diagnostic or prognostic purposes.
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introDuction
The relationship between cardiovascular risk factors and intracranial vascular disease in 
patients with a recent TIA or minor stroke is difficult to ascertain. This is at least partly due 
to the inaccessibility of particularly small brain vessels, the difficulty to relate, with certainty, 
brain infarcts on CT or MRI to intracranial disease, and the invasive nature of some radiological 
imaging procedures. We do know, however, that certain established cardiovascular risk factors, 
such as hypertension and diabetes mellitus, are related to cerebral white matter lesions1 and 
to silent, mostly lacunar, brain infarcts on CT and MRI.2 Of other cardiovascular risk factors like 
serum cholesterol level, the relationship with manifestations of intracranial vascular disease still 
remains to be elucidated.3
Ultrasonography may play a role in determining the relationship between these cardio-
vascular risk factors and intracranial atherosclerosis, since the major arteries within the brain 
can be relatively easily, non-invasively, and dynamically monitored by means of transcranial 
Doppler ultrasound (TCD).4 With TCD, flow velocities in the large arteries in the brain can be 
easily assessed through the temporal bone window.5 Moreover, the cerebrovascular reactiv-
ity to a vasodilatory stimulus like CO2, can be assessed with TCD.
6 This is thought to reflect 
the vascular reserve capacity in the brain, and predicts stroke in patients with a severe carotid 
artery occlusion.7
Before TCD parameters could be used as valid diagnostic or prognostic factors, their 
relationship with conventional cardiovascular risk factors needs to be studied, because these 
risk factors are likely to influence either arterial flow velocity in the major cerebral arteries, or 
cerebrovascular reserve capacity, or both. Previous studies have shown that the mean flow 
velocity in the major arteries in the brain is sex- and age- dependent.8,9 Some studies have also 
shown a sex- and age-dependent effect on cerebrovascular reactivity, measured by transcranial 
Doppler ultrasono graphy.10
We therefore studied the relationship between established cardiovascular risk factors and 
TCD parameters such as mean flow velocity, peak systolic flow velocity, end diastolic flow veloc-
ity, pulsatility index, and cerebrovascular reactivity to CO2, in a large series of patients with a 
recent TIA or minor ischemic stroke.
methoDs
subjects
We studied patients from the Rotterdam TCD study, a prospective study that investigates the 
diagnostic and prognostic value of TCD in patients with a recent TIA or ischemic non-disabling 
stroke. Inclusion criteria were a recent (<6 months) TIA or non-disabling ischemic stroke; 
excluded were patients with a mechanical heart valve and patients with a planned carotid 
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endarterectomy. Only patients who were over 18 years of age and gave informed consent were 
included in our study.
The study was approved by the institutional review board and medical ethics committee. Oral 
and written informed consent was obtained from all participants, and kept on file.
tcD recordings
All patients underwent TCD examination (Multidop X-4, DWL, Sipplingen, Germany). TCD 
examination was performed within 6 months after TIA or non-disabling ischemic stroke. In all 
patients peak flow velocity (PSV) and enddiastolic flow velocity (EDV) was measured with a 
handheld 2 MHz probe in both middle cerebral arteries (MCAs). Mean flow velocity (MFV) was 
calculated as EDV + 1/3(PSV-EDV). The pulsatility index (PI) was calculated as (PSV-EDV)/MFV. 
After that, the mean flow velocity in the MCA on both sides was measured continuously with 
2x2MHz probes, held in position by a metal headband. Patients breathed through a tightly 
fitting air mask. Carbon dioxide concentrations in this mask were measured continuously with 
a carbon-dioxide analyzer (Multinex, Datascope). End-tidal CO2 pressure was assumed to reflect 
arterial CO2.
11 Patients first breathed room air through the mask for at least two minutes until 
the mean flow velocity in the MCA had stabilized. Patients then breathed 5% carbon dioxide 
in oxygen for at least two minutes, until the mean flow velocity in the MCA had stabilized for 
at least 30 seconds. The mean flow velocity in both MCA’s was measured during inspiration of 
normal air and during inspiration of 5% carbon dioxide in oxygen, both times after stabilization 
of the mean MCA flow velocity. TCD-8 software (DWL) to determine the cerebrovascular CO2-
reactivity (CVR) was used. All data were stored on hard disk for off-line analysis. We calculated 
the cerebovascular CO2-reactivity as the percentage rise in mean flow velocity during hyper-
capnia.
All TCD recordings were done by one investigator (A.W.). Blood pressure was measured auto-
matically with a self-inflating cuff (Dynamap, Datascope, The Netherlands) before and during 
the TCD recordings.
Laboratory investigations
Total cholesterol, LDL-cholesterol, and HDL-cholesterol levels were measured by means of 
standard methods, with a Roche/Hitachi 917 (Mannheim, Germany). The cholesterol-HDL ratio 
was calculated. Blood samples were taken at least five days after the onset of the TIA or ischemic 
stroke.
Ancillary investigations
All patients underwent routine workup including neurological examination, a CT scan to rule 
out hemorrhage, and ECG. A duplex-ultrasound scan of the carotid arteries was made in all 
patients with an anterior circulation stroke.
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risk factors
Hypertension was defined by a regular blood pressure exceeding 140/90 mm Hg during 2 epi-
sodes of continuous blood pressure measurement or use of anti-hypertensive drugs. Diabetes 
was defined by fasting serum glucose over 7.9 mmol/l, or non-fasting serum glucose over 11.0 
mmol/l, or use of antidiabetic medication. Regular drinking of alcohol entailed an intake of at 
least 1 unit per week. Smoking was defined as smoking of at least one cigarette or cigar a day on 
average.
statistical analysis
The mean of the right and left flow velocity parameters and the mean of the right and left 
CVR were used for the analyses if both MCA’s could be insonated adequately. In patients with 
one-sided window-failure, TCD parameters in the contralateral MCA were used. Student’s t-test 
and linear regression analysis, two-tailed, was used to determine the relationship between the 
baseline characteristics, major risk factors and TCD parameters in order to detect possible con-
founding factors. A p-value smaller than 0.05 was considered to indicate statistical significance. 
No adjustments for multiple testing were made. After that, multiple linear regression analysis 
was used to adjust the relationship between TCD parameters and each risk factor for the effects 
of the other vascular risk factors.
resuLts
We included 598 consecutive patients in our study. In 4 patients the diagnosis was revised shortly 
after inclusion (1 patient had Multiple Sclerosis, 2 had partial epilepsy, and 1 had migraine), 
which left 594 patients. In 104 of these, we failed to obtain adequate Doppler data due to two-
sided window failure or other limitations. Therefore, 490 patients were included in the present 
analysis. Mean age was 60 years, and two thirds of the patients were men. Approximately half of 
the patients had had transient symptoms and more than 75% had focal ischemia in the anterior 
circulation. Almost one third of the patients were current smokers, nearly half of the patients had 
hypertension, and approximately 17% had diabetes mellitus (Table 1). Nearly 25% of the patients 
had one-sided window failure. Age in patients with window failure was significantly higher than 
in patients without window failure (60 ± 13 vs. 71 ± 10, p<0.001). Window failure was more often 
present in female patients than in male patients (31% vs 9%, p<0.001). The distribution of hyper-
tension, diabetes, and serum cholesterol level did not differ significantly between patients with 
window failure and patients without window failure. The proportion of patients who were current 
smokers was lower in patients with window failure as compared to patients without window 
failure (16 vs. 28%, p<0.05).
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No statistically significant difference was observed between the TCD parameters of the 
mean of left and right MCA and between the TCD parameters on the symptomatic and the 
asymptomatic side.
Age
All cerebral blood flow velocity measures (MFV, PSV, EDV), but not cerebrovascular CO2-reactiv-
ity declined significantly with increasing age. The pulsatility index increased significantly with 
increasing age. After adjustment for other cardiovascular risk factors, these relationships did 
not change in size or direction. In women the decline in cerebral flow velocity was higher than 
in men: -5.0 cm/s vs. –2.8 cm/s per 10 years of age.
sex
Blood flow velocity was higher in female than in male patients. This sex-related difference 
in cerebral flow velocity was present in younger people. After the age of 60 there was no 
table 1: Patient characteristics.
Men N=324 Women N=166 All N=490 p
Demographics
Age, years (mean ± SD) 62 ± 12 56 ± 14 60 ± 13 <0.0001
Stroke characteristics
TIA 169 (52%) 94 (56%) 263 (54%) NS
Anterior circulation TIA or stroke 253 (80%) 139 (84%) 392 (82%) NS
Infarct on CT scan (old or recent) 158 (49%) 65 (39%) 223 (46%) 0.046
Lacunar syndrome 116 (36%) 59 (36%) 175 (36%) NS
White matter lesions 47 (14%) 14 (8%) 61 (12%) 0.055
Risk factors
Smoking, present 95 (29%) 43 (26%) 138 (28%) NS
Alcohol consumption 323 (66%)
Hypertension 179 (55%) 78 (47%) 257 (52%) 0.088
Diabetes 48 (15%) 29 (17%) 77 (16%) NS
Previous TIA or stroke 75 (23%) 33 (20%) 108 (22%) NS
Previous myocardial infarction 43 (13%) 10 (6%) 53 (11%) 0.015
Carotid artery stenosis (≥70%) 30 (9%) 7 (4%) 37 (7%) 0.046
Body-mass-index, kg/m2 (mean ± SD) 26.2 ± 3.4 26.1 ± 4.7 26.2 ± 3.9 NS
Use of cholesterol lowering medication 83 (26%) 38 (24%) 121 (25%) NS
Cholesterol
Total cholesterol,mmol/l (mean ± SD) 5.6 ± 1.1 6.0 ± 1.2 5.7 ± 1.2 <0.0001
HDL-cholesterol, mmol/l (mean ± SD) 1.2 ± 0.4 1.5 ± 0.5 1.3 ± 0.4 <0.0001
LDL-cholesterol, mmol/l (mean ± SD) 3.8 ± 1.1 3.8 ± 1.1 3.8 ± 1.1 NS
Cholesterol-HDL ratio (mean ± SD) 5.0 ± 1.7 4.3 ± 1.6 4.7 ± 1.6 <0.0001
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difference in MFV, PDV, and EDV between men and women. No difference in cerebrovascular 
CO2-reactivity was found between male and female patients.
current smoking
In patients who were still smoking at the time of TCD investigation the MFV and PSV was 
higher than in patients who had quit smoking or had never smoked at all. After adjustment for 
age, however, the relationship between smoking and the MFV was not statistically significant 
anymore.
hypertension
In hypertensive patients the MFV was lower, and the PI was higher than in normotensive 
patients unadjusted for other risk factors. These relationships did not remain statistically signifi-
cant after adjustment for age. The cerebrovascular CO2-reactivity reactivity was 3.1% (p<0.03) 
lower in patients with hypertension (Table 3), and 4.1% (p=0.01) lower after adjustment for the 
remaining vascular risk factors (Table 4).
Diabetes
MFV and PSV were higher in diabetic patients, whereas PI was lower in diabetic patients. After 
adjustment for age and other vascular risk factors, these relationships did not change in size 
or direction and remained statistically significant. Diabetes was not related to cerebrovascular 
CO2-reactivity.
table 2: TCD parameters in a cohort of 490 patients with a TIA or minor stroke.
TCD Parameter Men N=324 Women N=166 All N=490 P
Mean of both sides
 Mean flow velocity (cm/s) 49 ± 15 56 ± 13 51 ± 14 <0.0001
 Peak systolic flow velocity (cm/s) 81 ± 23 90 ± 20 84 ± 22 <0.0001
 Enddiastolic flow velocity (cm/s) 33 ± 12 38 ± 12 35 ± 12 <0.0001
Pulsatility index 0.95 ± 0.22 0.89 ± 0.20 0.93 ± 0.22 0.008
  Cerebrovascular CO2-reactivity (% increase in 
MFV)
33.4 ± 16.2 33.7 ± 15.2 33.5 ± 16.0 NS
Symptomatic side
 Mean flow velocity (cm/s) 49 ± 19 57 ± 15 51 ± 18 <0.0001
 Peak systolic flow velocity (cm/s) 80 ± 28 92 ± 23 84 ± 27 <0.0001
 Enddiastolic flow velocity (cm/s) 33 ± 16 39 ± 13 35 ± 12 <0.0001
Pulsatility index 0.95 ± 0.25 0.89 ± 0.23 0.98 ± 0.26 0.0426
  Cerebrovascular CO2-reactivity (% increase in 
MFV)
32.8 ± 16.5 34.6 ± 15.6 33.2 ± 16.2 NS
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total serum cholesterol
Per mmol increase in total serum cholesterol, MFV increased by 2.5 cm/s (95% confidence 
interval 1.4 to 3.6, p<0.0001), but not after adjustment for age and sex. The cerebrovascular 
CO2-reactivity decreased significantly with increasing total serum cholesterol. This was 
observed after adjustment for remaining vascular risk factors. Twenty-five percent of the 
patients were using cholesterol lowering drugs (statins) at inclusion in the study. We observed 
table 3 Relationship of major vascular risk factors with MFV, PI, and cerebral CO2-reactivity the MCA, 
measured by transcranial Doppler ultrasound. Unadjusted, linear regression analysis. Effect size per unit of 
risk factor has been given, with 95% confidence limits.
Mean flow velocity Mean PI Mean cerebrovascular CO2-reactivity
Age -4.0cm/s/10yrs
(-5.0 to -3.1)
0.10/10yrs
(0.08 to 0.11)
0.7%/10yrs
(-0.4 to 1.9)
Male Sex -6.0 cm/s
(-8.6 to -3.3)
0.04
(-0.00 to 0.09)
- 0.1%
(-3.2 to 3.1)
Current smoking 3.3 cm/s
(0.5 to 6.2)
-0.06
(-0.1 to -0.01)
- 1.9%
(-5.1 to 1.4)
Hypertension -3.2 cm/s
(-5.7 to -0.6)
0.06
(0.02 to 0.10)
- 3.1%
(-6.0 to -0.2)
Diabetes 4.0 cm/s
(0.5 to 7.5)
0.07
(0.01 to 0.12)
- 0.8%
(-4.9 to 3.3)
Total serum cholesterol 2.5cm/s/mmol
(1.4 to 3.6)
-0.01/mmol
(-0.03 to 0.01)
- 1.3%/mmol
(-2.6 to 0.0)
table 4 Relationship of major vascular risk factors with MFV, PI, and cerebral CO2-reactivity the MCA, 
measured by transcranial Doppler ultrasound. Linear regression analysis adjusted for age, sex, hypertension, 
diabetes, and total cholesterol. Mean cerebrovascular CO2-reactivity also adjusted for change in blood 
pressure during hypercapnia. Effect size per unit of risk factor has been given, with 95% confidence limits.
Mean flow velocitya Mean PIb Mean cerebrovascular CO2-reactivity
c
Age -3.5cm/s/10yrs
(-4.5 to -2.5)
0.08/10yrs
(0.07 to 0.10)
1.1%/10yrs
(-0.1 to 2.3)
Male Sex -2.9 cm/s
(-5.5 to -0.3)
0.01
(-0.03 to 0.04)
-0.9%
(-4.2 to 2.4)
Current smoking 1.7 cm/s
(-1.0 to 4.4)
-0.02
(-0.06 to 0.02)
-2.5%
(-5.8 to 0.9)
Hypertension -0.2 cm/s
(-2.7 to 2.4)
-0.00
(-0.04 to 0.03)
-4.1%
(-7.3 to -1.0)
Diabetes 5.6 cm/s
(2.1 to 9.1)
0.07
(0.02 to 0.12)
-0.3%
(-4.8 to 4.1)
Total serum cholesterol 2.4 cm/s/mmol
(1.4 to 3.5)
-0.01/mmol
(-0.03 to 0.00)
-1.3%/mmol
(-2.6 to -0.0)
a. F=16.56, (prob>F)<.00001,
b. F=24.47, (prob>F) <.00001.
c. F= 2.15 (prob>F)=.0377
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no statistically significant relationship of cholesterol lowering drugs with mean flow, mean 
Cerebral CO2-reactivity or mean pulsatility index.
other confounding factors
Adjustment for blood pressure during TCD investigation did not change these figures signifi-
cantly. After exclusion of the 37 patients with carotid stenosis, flow measures and CO2 reactivity 
did not change significantly.
Discussion
In this study, we found that cardiovascular risk factors for atherosclerosis were significantly 
related to flow velocities in the large arteries in the brain in patients with a recent TIA or isch-
emic stroke. Blood flow velocity in the MCA decreases with age, and is lower in men than in 
women. Blood flow velocity in the MCA increases with total serum cholesterol, and is increased 
in diabetics compared to non-diabetics. Cerebrovascular CO2-reactivity is lower in hypertensive 
patients and decreases with increasing total serum cholesterol.
Before our results can be accepted, some methodological issues need to be discussed. 
Firstly, in our study 25% of the patients had an inadequate acoustical window. These patients 
were predominantly elderly female patients. Although this proportion matches that of other 
studies,4,12,13 it implies that our findings are not representative for the entire population of 
patients with recent TIA or stroke.
Secondly, we were not able to relate the results of Doppler ultrasound to other imaging 
techniques, such as digital subtraction angiography or MR or CT angiography, which could 
have corroborated our results. On the other hand, flow velocity and CO2 reactivity is deter-
mined by exactly the part of the intracranial vasculature that cannot be visualized by MR or CT 
angiography. Thirdly, we calculated the cerebrovascular CO2 reactivity as the relative increase 
in MFV in the MCA during hypercapnia. Most studies have used the percentage increase in 
MFV per kPa CO2 rise in end-tidal CO2. Calculating the cerebrovascular CO2 reactivity per kPa 
increase in end tidal CO2 should preferably be done because the MFV is dependent on the 
end-tidal CO2.
14 The relationship between the percentages administered CO2 and increase in 
MFV is not linear, but is S-shaped, and a maximum increase in MFV is only reached after at 
least 8% CO2.
15 Calculating the increase of the MFV per increase in kPa CO2 would therefore 
enhance the relationship with other (vascular risk) factors. In our study, however, end-tidal CO2 
measurements failed in substantial number of patients due to technical limitations. Despite the 
fact that we calculated the cerebral CO2 reactivity as the relative increase in MFV in the MCA, 
and not the relative increase in MFV in the MCA per kPa rise in end-tidal CO2, the relationship 
of hypertension and cholesterol with the cerebral CO2 reactivity was statistically significant.
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Age- and sex-related differences in cerebral blood flow velocity have been reported previously 
in population-based studies,10 in healthy volunteers14,16,17 and in patients with a previous neu-
rological event.8 The decline in MFV with increasing age is probably caused by flow reduction 
in the MCA 8. Hormonal effects may play an important role in the difference in flow velocities in 
the MCA between men and women under the age of 60 years.18 Gender-related differences in 
MCA diameter could also play a role in this observed difference in flow velocities between men 
and women.19 This gender-difference is consistently observed in patients at a younger age, 
but not in elderly patients.8,10,14 Since the vessel diameter is not age-related, this probably only 
plays a minor role in the observed difference in flow velocity. Moreover, Kastrup et al.20 have 
reported a difference in cerebrovascular CO2 reactivity between patients with and patients 
without hormonal replacement therapy: in patients with hormonal replacement therapy, the 
cerebrovascular CO2 reactivity was higher than in patients without hormonal replacement 
therapy. We could not make this distinction in our study, since very few patients received 
hormonal replacement therapy. However, in our study no difference in cerebrovascular CO2 
reactivity was found between premenopausal women and postmenopausal women.
Interestingly, the risk factors for atherosclerosis did not have a unidirectional relation with the 
cerebral flow velocities. Age and sex showed inverse relations with the flow velocity parameters 
in the MCA, whereas cholesterol level showed a positive relation with the flow velocity param-
eters in the MCA. This may be explained by the fact that hypercholesterolemia is associated 
with increased peripheral vascular resistance, which can lead to increased cerebral flow velocity 
in the MCA.21
It is likely that the relationship between hypertension and cholesterol on the one hand and 
decreased cerebrovascular CO2 reactivity on the other reflects the presence of small vessel 
disease. The relationship between small vessel disease and hypertension has been well estab-
lished.22 An impaired cerebrovascular CO2 reactivity has previously been associated with small 
vessel disease or lacunar infarction.1,23-25 No interaction with statin treatment was noted.
Our results indicate that the cerebral flow velocity in the MCA is influenced by multiple interact-
ing factors. This implies that in future studies of TCD parameters as a prognostic or diagnostic 
factor in patients with stroke or TIA, ultrasound findings will have to be adjusted for age, sex, 
diabetes, total serum cholesterol level, and possibly also for hypertension.
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Skull thickness and bone density as predictors 
of an inadequate acoustical temporal bone 
window in transcranial Doppler ultrasound
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AbstrAct
Transcranial Doppler (TCD) ultrasonography may provide important diagnostic and prognostic 
information in patients with ischemic stroke or transient ischemic attack. TCD also enhances 
the effect of thrombolytic treatment in patients with acute stroke. In some patients, especially 
elderly women, TCD cannot be performed because of temporal bone window failure (WF). We 
investigated whether skull thickness or bone density on computed tomography scans predicts 
WF. In 182 patients with a transient ischemic attack or minor ischemic stroke, skull thickness and 
bone density measurements were made at the level of the temporal bone window. Multiple 
logistic regression analysis was used to relate independent variables to WF, and to adjust the 
estimates for possible confounding factors. TCD signals were absent on the symptomatic side 
in 22 female and 11 male patients (18%). Both skull thickness and radiodensity at the level of 
the temporal bone window were strongly related to WF as well as age and female gender. After 
adjustment according to age and gender, skull thickness at the temporal bone window was an 
independent prognostic factor of WF (Odds Ratio: 2.3 per mm increase in skull thickness, 95% 
C.I.: 1.4 to 3.8). Radiodensity of the temporal bone decreased with age in women (-52 HU per 
10 years over 50 years of age, 95% C.I.: -73 to -30), but in men (-10 HU per 10 years over 50 years 
of age, 95% C.I.: -33 to 13), no statistically significant association was observed. We computed 
probabilities of WF for each patient individually. With a probability cut point of 50%, 33% of the 
patients with WF and 97% of the patient without WF were correctly identified. The area under 
the ROC curve of this simple prediction model including age, gender, and skull thickness was 
0.88; the area under the ROC curve of a gender-stratified model including age, skull thickness, 
and radiodensity was 0.90. This difference was not statistically or clinically significant p=0.13). 
WF is more common in women, because density of the temporal bone in elderly women is 
low. Absence of WF can be predicted by a combination of three simple parameters: skull thick-
ness, age, and gender. This may help to select patients with ischemic stroke for diagnostic TCD 
screening and to facilitate targeted delivery of ultrasound-enhanced thrombolysis.
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introDuction
Transcranial Doppler (TCD) ultrasonography can be used to assess intracranial blood flow in a 
non-invasive way. It may provide important diagnostic and prognostic information in patients 
with a recent transient ischemic attack (TIA), or minor stroke, and in patients with acute 
ischemic stroke 1,2. Furthermore, experimental studies have demonstrated that reperfusion is 
reached more often and more quickly when intravenous thrombolytic agents are combined 
with a transcranial ultrasound beam directed at the thrombus 3,4. More recently, several clinical 
observations and one clinical phase II trial (CLOTBUST) showed that ultrasound enhances the 
effect of thrombolytic agents on reperfusion in patients with an acute cerebral infarction in the 
middle cerebral artery territory. Whether ultrasound enhanced thrombolysis improves outcome 
in patients with acute ischemic stroke is currently being investigated in a phase III clinical trial 
(CLOTBUST II) 5,6. Usually, TCD monitoring can be easily and quickly performed , but in 5–37% 
of the patients, however, no adequate Doppler signal can be found because of an inadequate 
acoustic temporal window or window failure (WF) 7-9. TCD can be a time-consuming investiga-
tion in case of an inadequate signal in patients with insufficient temporal bone window.
The temporal bone window is the thinnest area of the lateral skull located closest to the ear. 
It allows for an ultrasound beam to invade and be reflected. Numerous studies have reported 
that an inadequate temporal bone window is more common in older women 10-12, and in non-
Caucasians8. Moreover, an inadequate temporal bone window is also related to thickening of 
the skull 13-15.
We studied the relationship of skull thickness and density of the temporal bone with WF to 
determine if WF can be predicted easily and accurately.
methoDs
study population
We retrospectively studied computed tomography (CT) scans of patients from a prospective 
cohort study in which we investigated the diagnostic and prognostic value of TCD in patients 
with a recent TIA or ischemic non-disabling stroke. Inclusion criteria were a recent (<6 months) 
TIA or non-disabling ischemic stroke. Patients had to be over 18 years of age, and had to give 
informed consent to be included in this study. The study was approved by the Medical Ethics 
Committee and Review Board of the Erasmus MC in Rotterdam, The Netherlands. Patients had 
to be independent in most activities in daily living, corresponding with grade 3 or better on the 
modified Rankin scale 16,17.
All patients underwent TCD examination and received a routine check up, including a com-
puted tomography (CT) scan, neurological and physical examination, routine laboratory tests, 
and a duplex of the carotid arteries in case of an anterior circulation stroke or TIA.
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tcD examination
TCD examination was performed with a Multidop X4 (DWL, Sipplingen, Germany) using a 2 
MHz handheld probe. Power was set at 147 mW and increased if necessary to 200 mW. Since the 
TCD examination was originally performed for different purposes than to study the relationship 
between CT measurements and WF, we searched for a signal of the middle cerebral artery (MCA) 
on both symptomatic and asymptomatic side at a depth ranging from 41 – 65 mm for at least 
10 minutes. A signal was considered adequate if an envelope could be visualized around the 
Doppler spectrum for the calculation of the mean, peak and end-diastolic velocities (Figure 1). 
WF was only considered when neither an MCA signal nor any other arterial signal could be 
visualized adequately in order to rule out an MCA occlusion. We did not use any contrast agents 
during the TCD examination. All TCD-examinations were performed by one investigator (A.W.), 
who was blinded to the results of the measurements performed on the CT-scans.
Quantitative ct scan measurements
All CT scans were made on two Philips Somatom Plus 4 CT scanners (Philips BV, The Nether-
lands) in Erasmus Medical Center Rotterdam from April 1998 to March 2000. All CT scans were 
performed as part of routine patient care. The CT scans were made with a slice thickness of 5 
mm. The CT scans were recovered from the digital archives in our hospital.
We measured skull thickness and radiodensity at a region of interest (ROI). We defined our 
ROI in the slice above the sella turcica just above the external meatus. The circular ROI was 
positioned at the level of the temporal bone window at the thinnest part of the skull. Both skull 
thickness and radiodensity were measured in the same ROI. Radiodensity measurements were 
performed by means of a Siemens Magic View® workstation (Siemens AG, Germany). After des-
ignating the ROI we calculated the mean radiodensity in Hounsfield Units (HU) for the ROI. To 
eliminate the contribution of non-bone elements in the ROI and the influence of partial volume 
effects in measuring the radiodensity, a cut point was determined at a level halfway between 
Figure 1: Image of an adequate transcranial Doppler ultrasonography signal of the MCA with a mean 
velocity of 47.1 m/s, peak-systolic flow velocity of 69 cm/s, and an enddiastolic flow velocity of 33 cm/s.
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the maximum and the minimum radiodensity in the ROI. This means that all components with 
radiodensities below the cut point were discarded in the second measurement, only leaving 
the bony parts of the skull to be taken into account when calculating the radiodensity of the 
temporal bone window.
Skull thickness was measured by means of a Philips Easy Vision® workstation (Philips BV, The 
Netherlands). The measurements were carried out three times on either side of the skull, all 
three close to each other inside the region of interest. On each side three lines were drawn 
from the outside of the skull to the inside at our ROI and the computer made graphs of the 
distribution of radiodensities along the lines that were drawn. The width of the bony skull was 
measured after applying this cut point to distinguish between bone and soft tissue. The mean 
of these three measurements was calculated. One observer (M.F.) performed the measure-
ments on the CT scans. This observer was blinded to the presence or absence of an adequate 
TCD signal.
statistical analysis
We analysed the temporal bone window on the symptomatic side in patients. The analysis was 
carried out with STATA 8 software (Stata Corporation, College Station, Texas USA). Differences 
between patients with WF and patients without WF were analysed using parametric tests or 
chi-square tests. A p-value below 0.05 was considered statistically significant. Multiple logistic 
regression analysis was used to relate independent variables to the occurrence of WF, and to 
adjust for possible confounding factors, such as age and gender. We evaluated the relation-
ship between WF and radiodensity and thickness of the temporal bone with a multiple logistic 
regression model adjusting for age and gender. We then created an interaction factor (skull 
thickness x radiodensity) to study if thickness and density were dependent on each other, i.c. 
if thicker bones had less radiodensity. For prediction, two models were created: one with three 
simple parameters including age, gender, and skull thickness, and a gender-specific model 
including age, skull thickness and radiodensity. The performance of these models for predic-
tion of WF was assessed by comparing the area under the receiver operating characteristics 
(ROC) curve. The ROC curve plots 1-specificity versus sensitivity for WF. The area under the ROC 
curve was calculated to assess the regression model’s performance in distinguishing between 
the presence and the absence of WF. An area of 1.0 represents a perfect test, whereas an area 
of 0.5 indicates a test with no discriminatory power. The area under the ROC curve is especially 
meaningful for comparing different tests or prediction models, as we did.18. The ROC curve was 
constructed after computing probabilities for each patient with the multiple logistic regression 
model.
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resuLts
285 consecutive patients were eligible for inclusion in this study. In 79 patients, the CT-images 
were not available at the time of study. In 6 patients, scans were made on a different type of CT 
scanner, and in 8 patients, the CT scan image was technically inadequate. This left 182 patients 
for analysis. Patients in whom the CT scan was not available for analysis did not differ from 
included patients with regard to age, gender, occurrence of WF.
WF was present in 33 (18%) patients. Patients with WF were older than patients without WF, 
72.4 ± 9.3 vs. 58.8 ± 13.9 years (mean ± SD) . WF was not present in patients under 50 years of 
age. Patients with WF were more often female than patients without WF (67% vs. 34%, p=0.001) 
(Table 1).
The mean skull thickness in the study population was 3.1 ± 0.9 mm (mean ± SD). The mean 
radiodensity at the temporal bone window on the symptomatic side was 1001 ± 163 HU (mean 
± SD) (Table 1). Skull thickness was related to age: 0.14 mm increase per 10 years over 50 years 
of age, 95% C.I.: 0.05 to 0.23, but not to gender: 3.2 ± 0.9 mm in women vs. 3.1 ± 1.0 mm in men. 
Radiodensity of the temporal bone decreased statistically significant with higher age in women 
(-52 HU per 10 years over 50 years of age, 95% C.I.: -73 to -30), but not in men (-10 HU per 10 
years over 50 years of age, 95% C.I.: -33 to 13) (Fig 2). Ethnicity was neither related to WF nor to 
skull thickness.
In patients with WF, skull thickness was 3.8 ± 1.1 mm compared to 3.0 ± 0.8 mm (mean ± SD) 
in patients without WF (p<0.001). Radiodensity of the temporal bone was lower in patients with 
WF (943 ± 146 HU) than in patients without WF (1014 ± 164 HU (mean ± SD), p=0.022) (Table 1). 
table 1: Baseline characteristics
Overall WF No WF
No. of patients 182 (100%) 33 (18%) 149 (82%)
Baseline
Age (yrs), mean ± SD 61.2 ± 14.2 72.4 ± 9.3 58.8 ± 13.9 p<0.000
 Male gender 109 (59.9 %) 11 (33%) 98 (66%) p=0.001
 Caucasian Race 162 (90 %) 30 (91%) 132 (89%) NS
Risk factors
 Hypertension 76 (41.8%) 17 (52%) 59 (40%) NS
 Diabetes Mellitus 21 (11.7%) 5 (15%) 16 (11%) NS
 Hyperlipidemia 54 (30.9%) 10 (31%) 44 (31%) NS
 Previous MI 22 (12.3%) 5 (16%) 17 (12%) NS
 Intermittent claudication 17 (9.5%) 1 (3%) 16 (11%) NS
CT measurements
 Skull thickness (mm), mean ± SD 3.1 ± 0.9 3.8 ± 1.1 3.0 ± 0.8 p<0.000
 Radiodensity (HU), mean ± SD 1001 ± 163 943 ± 146 1014 ± 164 p=0.022
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After adjustment for age and gender, the relationship between skull thickness and WF did not 
change (Table 2). Radiodensity of the skull on the symptomatic side, however, was no longer 
related to WF after adjustment for age and gender (Table 2). We also studied the possibility 
of interaction between skull thickness and radiodensity of the temporal bone by creating a 
new variable (skull thickness × radiodensity of the temporal bone). This interaction factor was 
related to WF, but not after adjustment for age and gender (Table 2).
We then constructed multiple logistic regression models for men and women separately, 
that included age, skull thickness, and radiodensity of the temporal bone, because radioden-
sity was very strongly related to age in women. In men, skull thickness, as well as radiodensity 
was related to WF (Table 3). In women, age and skull thickness were related to WF, whereas 
radiodensity was not (Table 3).
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Figure 2: Skull thickness (A) and radiodensity (B) at the level of the temporal bone window per age group 
for men and women.
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We calculated probabilities of WF for each patient individually, by means of a multiple 
regression model including age, gender, and skull thickness. In this model, age, sex, and skull 
thickness were independently related to WF (Table 4). Female gender was the strongest predic-
tor of the presence of WF. With a probability cut point of 50%, 33% of the patients with WF were 
correctly identified as having WF, and 97% of those without WF were correctly identified as 
having no WF. The positive predictive value with this probability cut point was 69%, the nega-
tive predictive value was 87%. With a probability cut point of 90% the positive predictive value 
increased to 100%, but the negative predictive value was 83%. The area under the ROC curve of 
the simple prediction model including age, gender, and skull thickness was 0.88; the area under 
table 2: Odds ratios for window failure for skull thickness (A) and radiodensity of the temporal bone (B).
A Unadjusted Adjusted for age 
and gender
Adjusted for 
age, gender, and 
radiodensity
Adjusted for age, gender, 
radiodensity and the interaction 
factor (skull thickness * density)† 
Skull thickness‡
OR (95% C.I.) 
2.37 (1.58–3.57) 2.33 (1.44-3.79) 2.49 (1.49-4.17) 3.71 (0.28-49.0)
† Odds ratio for WF for the interaction factor (skull thickness * density) was 1.00 (95% C.I.: 0.99-1.01) in this 
model
‡ per mm increase in skull thickness
B Unadjusted Adjusted for age 
and gender
Adjusted for age, 
gender, and skull 
thickness
Adjusted for age, gender, skull 
thickness, and the interaction 
factor (skull thickness * density)
Radiodensity§
OR (95% C.I.) 
0.76 (0.63-0.98) 1.00 (0.76-1.32) 0.86 (0.64-1.16) 0.99 (0.38-2.61) †
† Odds ratio for WF for the interaction factor (skull thickness * density) was 1.00 (95% C.I.: 0.99-1.01) in this 
modelc
§ per 100 HU increase in radiodensity of the temporal bone
table 3: Odds ratios for window failure, based on a multiple logistic regression models of age, skull 
hickness, and radiodensity, for men and women separately.
Window failure symptomatic side OR (95% CI)
Men Women
Age per 10 yrs over 50 yrs 1.71 (0.86 – 3.39) 4.08 (1.84 – 9.01)
Skull thickness per mm 3.58 (1.73 – 7.43) 2.42 (1.01 – 5.80)
Radiodensity per 100 HU 0.65 (0.44 – 0.93) 1.20 (0.79 – 1.83)
table 4: Odds ratios for window failure based on a logistic regression model of age, gender, and skull 
thickness.
Window failure symptomatic side OR (95% CI)
Age per 10 yrs over 50 yrs 2.58 (1.63 – 4.07)
Female gender 5.94 (2.21 – 15.9)
Skull thickness per mm 2.33 (1.44 – 3.79)
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the ROC curve of a gender-specific model including age, skull thickness, and radiodensity was 
0.90. This difference was not statistically or clinically significant p=0.13)
We calculated probability cut points of skull thickness for WF, as a function of age based on 
the simple logistic regression model including age, sex, and skull thickness. These results are 
shown in Figure 3. With this figure, estimation of the probability of WF for an individual patient 
can be made. For example, in an eighty-year old male patient with a temporal bone thickness of 
3.3 mm, the chance of WF would be less than 10% (black dot in Figure 3A). If this patient would 
be female, the probability of WF would increase to approximately 80% (black dot in Figure 3B).
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Figure 3: Dependency of cut points of skull thickness (mm) on age and gender to predict window failure 
with different probabilities for men (A) and for women (B). In women, the cut point is lower than in men. 
With this figure, estimation of the probability of WF for an individual patient can be made. For example, 
in an eighty-year old male patient with a temporal bone thickness of 3.3 mm, the chance of WF would 
be less than 10% (black dot in figure 2A). If this patient would be female, the probability of WF would 
increase to approximately 80%.
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Discussion
Our study confirms that skull thickness at the level of the temporal window is related to 
inadequacy of the ultrasound signal. Furthermore, skull thickness is more closely related to WF 
than radiodensity of the temporal bone. A decreased radiodensity of the bone at the temporal 
window was also related to WF, but not significantly so, after adjustment for age and gender.
Some methodological issues need to be discussed. First, selection bias could have occurred, 
since skull thickness and radiodensity measures could not be carried out in all patients, as the 
CT scan was not available for analysis at the time of our study. However, patients in whom 
the CT scan was not available for analysis did not differ from included patients with regard to 
age, gender, and occurrence of WF. We therefore think that the CT non-availability represents 
random error and does not bias the results of our study. Secondly, we did not use any contrast 
agents during TCD investigation. Contrast agents enhance assessment of intracranial cerebral 
arteries, however, the original protocol for this study did not allow for use of contrast agents.
In our study, age and gender are strongly related to WF. This confirms the results of previ-
ous studies 7,8,19. We used a simple method to determine skull thickness and density of the 
temporal bone window in vivo. Our observation that the temporal bone was thicker in women 
than in men is in concordance with other studies 13,20. Skull thickness in relation to WF has been 
measured in postmortem studies 21, and in clinical studies. 13,20. These studies have shown that 
skull thickness is related to the presence of WF. This can probably be explained by the notion 
that ultrasound is scattered by the cancellous bone in the diploe 22. Moreover, the thickness of 
the cancellous bone is related to the presence of WF 21.
In our study, radiodensity of the temporal bone was related to age, but only in women. 
Unadjusted, radiodensity was related to WF on the symptomatic side, but this relationship was 
neutralized by female gender. We therefore conclude that the high incidence of WF in elderly 
women is probably caused by loss of skull density. However, gender-stratified logistic regres-
sion models including radiodensity, did not predict WF more accurately than the simple logistic 
regression model including age, gender, and skull thickness. Recently, Kwon et al. 20 have 
described the relationship between inhomogeneity of temporal bone and WF. Most probably, 
loss of density leads to energy loss due to scattering of the ultrasound beam, and therefore to 
an inadequate Doppler signal 23 .
We showed that a simple logistic regression model of age, gender, and skull thickness could 
predict absence of WF in nearly all patients correctly. The positive predictive value, however, 
was only 69%, where 100% is desirable, since the percentage of false positive predictions 
needs to be as low as possible. Our study results may be particularly helpful when ultrasound 
enhanced thrombolysis has been proven to improve clinical outcome. CT measurements, that 
take approximately 5 minutes of time, may be helpful in avoiding TCD measurements in patients 
with a high probability of WF. This is important especially when this service is not available on 
a 24-hour basis. If skull thickness were to be used as a screening test to identify patients with 
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probable bone window failure, then the cut point should depend on the disutility of missing 
a patient with window failure and missing a patient without window failure. If both disutilities 
are considered equal, then a cut point of 50% should suffice. If thrombolysis is proven to be 
enhanced by TCD, and missing a patient without window failure is ten times worse that missing 
one with window failure, then the cut point would be 90%. We chose 90% to estimate how 
many patients should be screened. In our study, none of the men had a probability of more 
than 90% of having window failure. This means that in practice, only women would have to be 
screened for WF. No woman under 70 years of age had a probability of more than 90% of having 
WF. Only 21 women in our study were older than 70 years of age, of whom 3 had a probability 
of more than 90% of having WF, which means that the number needed to screen is 7 (female) 
patients.
Our relatively large study provides quantitative estimates of the contribution of skull density 
and thickness parameters to the occurrence of window failure. We conclude that both thick-
ness and density of the temporal bone are related to the presence of WF, but that skull density 
does not independently predict WF. Absence of WF can be predicted accurately in nearly all 
patients with ischemic stroke or TIA by means of three simple parameters: skull thickness, age 
and gender. This may help to select patients for diagnostic TCD screening and perhaps in the 
near future, to facilitate targeted delivery of ultrasound-enhanced thrombolysis.
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chapter 2.3
Diagnosis of ischemic stroke subtype and 
potential cardiac sources of embolism by 
transcranial Doppler ultrasonography. A 
systematic review
A.D. Wijnhoud
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AbstrAct
Background: High Intensity Transient Signals (MES) in Transcranial Doppler ultrasonography 
(TCD) monitoring may indicate micro-thromboembolism in patients with recent ischemic 
stroke or TIA. However, it is unclear whether TCD monitoring for MES is helpful in the diagnosis 
of a potential cardiac source of embolism (PCSE) and of stroke subtype (i.e. small-vessel disease 
or not).
Methods: We searched NLM Medline, Embase and cross-references in articles for published 
studies on TCD MES monitoring in patients with a TIA or ischemic stroke. Of each study we 
computed the sensitivity and specificity of MES for stroke subtype and for a PCSE. Next, we 
combined data from each study into a summary receiver operating characteristic (sROC) curve. 
We took into account the clinical characteristics of each study population, method of MES 
detection and whether technical details of TCD examination were reported. We contrasted the 
results of the meta-analysis with the findings in our own study.
Results: Thirteen studies were identified. There was heterogeneity in study design and methods 
between the studies, and technical details were not always reported in detail. Nevertheless, our 
analysis showed that in the nine studies that used a well-defined reference test for ischemic 
stroke subtype the specificity of TCD for non-lacunar stroke was 0.90, and sensitivity was 0.76. 
Sensitivity for PCSE in the eight studies that used a well-defined reference test was 0.74 and 
specificity was 0.65 at the optimal point of the sROC curve. In our own study sensitivity for 
stroke subtype was 0, and specificity was 0.91. For PCSE sensitivity was 0, and specificity was 
0.95. Sensitivity was low because this was not performed in the acute phase.
Conclusions: The sensitivity and specificity of MES detection with transcranial Doppler ultra-
sound in the diagnosis of PCSE is not high enough to recommend its use for screening prior to 
more invasive diagnostic investigations, such as transesophageal echocardiography. However, 
results in patients with a recent stroke, a confident diagnosis of non-lacunar stroke can be made 
when MES are detected with TCD.
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introDuction
Deciding whether a patient had a lacunar or a non-lacunar stroke can be quite difficult. Many 
patients had a short attack, have residual symptoms that are not very helpful, and their CT or 
MRI may be normal.1 Additional diagnostic information that helps to determine stroke subtype 
in such patients could be helpful. The “micro-embolic signals” (MES), detected by transcranial 
Doppler ultrasonography (TCD), may help in distinguishing non-lacunar (thromboembolic) 
from lacunar stroke. TCD could perhaps also be helpful in the detection of a potential cardiac 
source of embolism (PCSE). A truly non-invasive diagnostic investigation that could be used to 
identify patients, who will not benefit from transesophageal echocardiography (TEE), would be 
most welcome.
Monitoring for microembolic signals by means of TCD is not a standard investigation in 
stroke patients, and its potential clinical usefulness is unclear. In patients with a recent stroke or 
transient ischemic attack, MES are not uncommon.2-4 Several studies have shown that MES are 
more often present in patients with a cortical stroke2 and in patients with PCSE.5 However, the 
sensitivity and specificity of TCD (i.e. MES monitoring) for non-lacunar stroke or PCSE in these 
studies varied greatly. Although most studies used similar criteria for MES, comparison of the 
data is made difficult by differences in important other variables such as detection threshold,6-8 
method of MES-detection (automated, human observer, or a combination),7-9 or time window 
between stroke and TCD investigation.10 This diversity makes it difficult to draw conclusions 
about the diagnostic value of TCD in patients who had an ischemic stroke or TIA.
The purpose of this study was to determine the diagnostic value of TCD MES monitoring 
in patients with transient ischemic attack or ischemic stroke regarding stroke subtype and 
the presence of a PCSE. We therefore compared the data in a summary receiver operating 
characteristic curve as suggested by Moses et al.11 Finally, we compared the findings from our 
systematic review with the results of the Rotterdam TCD study, a cohort study of the prognostic 
and diagnostic value of TCD in 592 patients with a recent TIA or stroke.
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methoDs
selection of relevant studies
We searched NLM Medline, Embase, and cross references in articles for published studies on 
TCD MES monitoring in patients with a recent TIA or ischemic stroke. We used the following 
search keys: [(TIA OR stroke) AND (TCD OR transcranial Doppler ultrasonography)]. The articles 
were selected on the basis of their title and the information in the abstract. To be included in 
this review, the study should concern a series of patients with stroke or TIA who underwent 
TCD monitoring for MES. The results of the TCD investigation should be compared with a “gold 
standard” or “reference” diagnosis.
Definitions
Small vessel disease was defined according to the TOAST criteria:12 a lacunar syndrome with a 
normal CT, or as a CT showing a relevant lacunar infarct sized 1.5 cm in diameter or less without 
another cause of the stroke.
We defined PCSE according to the TOAST criteria,12 and included high risk sources of embo-
lism, such as atrial fibrillation, recent (<4 weeks) myocardial infarction, sick sinus syndrome, 
prosthetic cardiac valves and left atrial appendage or ventricular thrombus, and medium risk 
sources, such as patent foramen ovale, left atrial or ventricular aneurysm, mitral valve prolaps, 
old (1-6 months) myocardial infarction and atrial or ventricular septal defect. Preferably, the 
diagnosis of PCSE should have been confirmed by echocardiography.
criteria for inclusion of studies
We checked whether the study population and relevant clinical characteristics was described 
adequately to evaluate the diagnostic accuracy and reproducibility.13 Relevant characteristics 
that were considered in this review were time since onset of stroke, its vascular distribu-
tion, the presumed mechanism, especially whether the infarct was considered to be due to 
small vessel occlusion or not, age, and sex distribution. These characteristics may affect the 
accuracy of TCD: the test may perform well in certain subgroups and poorly in others, despite 
reasonable average values of accuracy. Verification bias occurs when patients with positive (or 
negative) diagnostic tests preferentially receive verification by the reference test. For example, 
patients with MES may have a higher chance of being referred for a cardiologic consultation 
and echocardiography than patients without MES. We noted whether patients had undergone 
thransthoracic or transesophageal echocardiography. We tried to estimate from the studies the 
ratio of the verification rate in patients with MES and the verification rate in patients without 
MES. Review bias can be introduced when either the diagnostic test or the reference procedure 
is assessed without objectivity in the interpretation. We noted whether the TCD examination 
was carried out without knowledge of the results of the reference test or other investigations. In 
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addition, we checked whether the reference test (for example echocardiography or a CT scan) 
was interpreted without knowledge of the results of the TCD-investigation.
tcD investigation: technical aspects.
MES were defined as transient Doppler microembolic signals, usually lasting less than 300 mil-
liseconds. The amplitude of the Doppler microembolic signal should be at least 3 decibel (dB) 
higher than that of the background blood flow signal, within the appropriate dynamic range 
of bi-directional Doppler equipment. In addition, MES are unidirectional within the Doppler 
velocity spectrum and accompanied by a “snap,” “chirp,” or “moan” on the audible output.8 We 
checked if a fixed detection threshold was used in each study.
We checked whether studies reported parameters that are likely to influence the sensitivity 
and specificity of TCD, as recommended by the International Consensus Committee on Micro-
embolus Detection.8 These parameters include ultrasound device, insonated artery, insonation 
depth, algorithms for signal intensity measurement, detection threshold, axial extension of 
sample volume, fast Fourier transform (FFT) size (number of points used), FFT length (time), FFT 
overlap, transmitted ultrasound frequency, and recording time.
method of quantitative analysis
We computed for each study the sensitivity and specificity for non-lacunar stroke and PCSE 
after translation of the results in a simple 2´2 table. Sensitivity for non-lacunar stroke was com-
puted by the number of MES-positive patients with a non-lacunar stroke divided by the total 
number of patients with a non-lacunar stroke. Sensitivity for PCSE was taken as the number 
of MES-positive patients with a PCSE divided by the total number of patients with a PCSE. 
Thus, sensitivity was estimated by taking the probability of a positive test in patients with the 
condition of interest; this will be referred to as the True Positive Rate (TPR). The specificity for 
non-lacunar stroke was defined as the number of MES-negative patients with a lacunar stroke 
divided by the total number of patients with a lacunar stroke. The specificity for PCSE was 
assessed as the number of MES-negative patients without a PCSE divided by the total number 
of patients without a PCSE. Similarly, 1-specificity represents the probability of a positive test in 
patients without the condition or disease of interest; this will be referred to as the False Positive 
Rate (FPR). The sensitivity and specificity for PCSE was determined after exclusion of patients 
with a significant carotid stenosis (>50% by duplex ultrasound), since carotid stenosis can be 
an important source of MES.14-17
TPR and FPR are not independent of each other since both may increase or decrease when 
the threshold for a positive test, i.e. dB threshold, is changed. TPR can be plotted against FPR 
in a receiver operating characteristic (ROC) curve. An ROC curve is a path in the unit square, 
rising from the lower left corner, where TPR and FPR are both zero, to the upper right corner, 
where TPR and FPR are both one. This ROC curve can be generated from one set of data with the 
same settings with only a varying threshold. An ROC curve cannot be generated from different 
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studies without an exact match of study population and analysis characteristics. To determine 
the effect of interstudy differences, we carried out a correlation analysis with parameter D 
(Appendix A), the natural logarithm of the odds ratio, which is a measure for how well the test 
discriminates between the population with and without a lacunar infarct, or with and without 
PCSE. This analytical method is described by Moses et al.11 The resulting summary ROC curve 
is not based on individual data, but on sensitivity and specificity of each study separately, and 
takes into account the number of patients in each study. The calculations were performed using 
a standard spreadsheet.
rotterdam tcD study
Our own data were derived from the Rotterdam TCD study.18 This study was designed to 
evaluate the diagnostic and prognostic value of transcranial Doppler ultrasonography in a 
prospective cohort of unselected patients with a recent TIA or minor ischemic stroke. Patients 
were 18 years and older and had the index event within the preceding 6 months. They were 
independent (a score of 3 or less on the modified Rankin scale),16 and the TIA or stroke was 
of presumed atherosclerotic origin; this implied that patients with a mechanical heart valve 
and a proven dissection were excluded. Patients with atrial fibrillation or a significant symp-
tomatic carotid artery stenosis (>70% stenosis, NASCET criteria) were also excluded. The study 
population consisted of patients for whom no other treatment than risk factor modification 
and antiplatelet medication was available.
In our study, all patients underwent routine workup including neurological examination, 
a CT scan to rule out hemorrhage, and an ECG. These investigations were performed on 
admission or first visit to the outpatient clinic, always before the TCD investigation. Risk factors 
(diabetes mellitus, smoking, hypertension, increased serum cholesterol level) were assessed. A 
duplex-ultrasound scan of the carotid arteries was made in all patients with an anterior circula-
tion stroke. Echocardiography was done in randomly selected patients, but also in patients with 
a history of cardiac disease, abnormalities on ECG, or a cardiac bruit on physical examination. To 
address the value of TCD in diagnosing stroke subtype, we included only patients with a recent 
infarct on the CT scan. To address the value of TCD in diagnosing PCSE, we included all patients 
in whom echocardiography was performed.
Our study included patients in the subacute phase of stroke. This differed significantly from 
the other studies, which were acute phase studies. We therefore chose not to directly compare 
the results of our study to the other studies.
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resuLts
We identified twelve studies2-4,10,19-26 that addressed the value of MES in diagnosing stroke 
subtype, and twelve studies3,5,10,19-27 that addressed the diagnostic value of MES in screening 
for a PCSE. Eleven of these studies were selected for both purposes. Their characteristics, quality 
aspects, technical aspects, and results are described in Tables 1-4.
table 1: Characteristics of the selected studies
Author Year TIA (%) Age (years) Sex (% Male) Time- since onset
A: Stroke subtype
Grosset et al. 1994 20 67 (32-96) 60 <48 hrs.
Daffertshofer et al. 1996 26 63.0 ± 13.9 70 <4 weeks
Kaposzta et al. 1999 0 69.6 ± 12.1 52 <72 hrs.
Del Sette et al. 1997 Unknown 69.4 ± 13.9 68 <72 hrs
Koennecke et al. 1997 15 62 ± 14 67 <48 hrs.
Koennecke et al. 1998 26 60.6 ± 14 63 <48 hrs.
Sliwka et al. 1997 Unknown 62.5 (29-90) 65 <1 week †
Lund et al. 2000 12 73.0 ± 11 53 < 72 hrs. ‡
Serena et al. 2000 29 65.1 ± 12.3 74.2 69.5 ± 44 hrs.
Iguchi et al. 2007 0 71.6 54 <24 hrs.
Poppert et al. 2006 Unknown 59.4 64 5.3 ± 3.5 days
Idicula et al. 2010 5 70 ± 15.5 72.5 < 6 hrs.
B: Potential cardiac source of embolism % Mechanical 
heart valves 
Daffertshofer et al. 1996 26 63.0 ± 13.9 70 <4 weeks 0
Kaposzta et al. 1999 0 69.6 ± 12.1 52 <72 hrs. 0
Del Sette et al. 1997 Unknown 69.4 ± 13.9 68 <72 hrs 0
Koennecke et al. 1997 15 62 ± 14 67 <48 hrs. 10
Koennecke et al. 1998 26 60.6 ± 14 62 <48 hrs. 2
Sliwka et al. 1997 Unknown 62.5 (29-90) 65 <1 week † 0
Tong et al. 1995 0 70 ± 14 58 <48 hrs. 7
Lund et al. 2000 12 73.0 ± 11 53 < 72 hrs. ‡ Unknown
Serena et al. 2000 29 65.1 ± 12.3 74.2 69.5 ± 44 hrs. Unknown
Iguchi et al. 2007 0 71.6 54 <24 hrs. 0
Poppert et al. 2006 Unknown 59.4 64 5.3 ± 3.5 days 0
Idicula et al. 2010 5 70 ± 15.5 72.5 < 6 hrs. Unknown
† A second TCD investigation was carried out 24 hrs later, and a third within one week
‡ A second TCD investigation was carried out 5 days later
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characteristics of the studies
The studies were published in the years 1994 through 2010. The studies were similar with 
respect to demographic characteristics of the study population, and the timing of the investiga-
tion relative to the onset of symptoms (24 to 72 hours in most, less than 4 weeks in one study).
technical aspects
Four of the 13 studies described the method of intensity measurement of the signal in detail. 
Information about the algorithm for MES detection was lacking in most studies. The detection 
threshold that was employed in each study varied from 3 to 9 dB.
None of the studies reported all 14 parameters suggested by the International Consensus 
Group on Microembolus Detection.8 Most of these parameters influence the intensity of a 
microembolic signal and may therefore affect test accuracy. Only five studies reported at least 
7 of the 14 parameters, and the remaining five studies reported less than 7. The parameters 
reported by all thirteen studies were the insonated artery, the transmitted ultrasound fre-
quency and the length of the recording time. All studies except two reported the depth of the 
insonated artery. Six studies reported the size of the sample volume. Only four studies reported 
the FFT-overlap. FFT length was never reported. Presumably, all studies used pulsed wave Dop-
pler ultrasound, but only two reported this information. Scale settings were reported in just one 
study. In all studies ultrasound frequency was 2 MHz.
Diagnosis of stroke subtype
The sensitivity for non-lacunar stroke ranged from 0.14 to 0.88 and the specificity ranged 
from 0.73 to 1.0 (Table 4). In the nine studies with a robust reference test, based on the 
TOAST criteria,12 specificity ranged from 0.82 to 1. In these studies, the mean D increased 
from 2.41 to 3.33, for a sensitivity of 0.76 and a specificity of 0.90 at the optimal point of the 
sROC (Fig.1). Sensitivity increased when TCD investigation was carried out sooner after stroke 
onset (Table 1 & 4, Figure 1).
Detection of likely sources of potential cardio-embolism
The sensitivity for PCSE ranged from 0.05 to 0.53 and the specificity from 0.58 to 1.0. The sen-
sitivity in studies that had not included patients with mechanical prosthetic heart valves was 
lower than in the other studies. The mean D was 1.40, for a sensitivity of 0.22 and a specificity of 
0.94. Since this heterogeneity may be partly caused by the noted differences in definition of the 
reference test, we made a distinction between eight studies where a PCSE was defined accord-
ing to the TOAST criteria,12 and the four remaining studies which simply described which kind 
of PCSE was observed. After this modification, sensitivity increased to 0.74 in the first group, but 
specificity decreased (0.65) at the optimal point on the sROC curve (Fig.2).
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Figure 1. Summary ROC curve for diagnosis of stroke subtype. The dotted line in the figure indicates the 
predefined range of interest, no data are available beyond that line. Nine studies (dots) met our criteria; 
the summary ROC curve of these studies is the continuous line in the figure. Three studies were excluded 
(triangels) because in these studies the stroke subtype was based on just the admission CT scan; the 
summary ROC curve of those studies is the interrupted line in this figure. Results of the present study 
represented by the asterisk.
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Figure 2. Summary ROC curve for diagnosis of a potential cardiac source of embolism. The dotted line in 
the figure indicates the predefined range of interest, no data are available beyond that line. Eight studies 
(dots) met our criteria; the summary ROC curve of these studies is the continuous line in the figure. Four 
studies were excluded (triangels) because in these studies the definition of PCSE was incomplete; the 
summary ROC curve of those studies is the interrupted line in this figure. Results of the present study are 
represented by the asterisk.
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characteristics of the rotterdam tcD study
Mean delay between stroke or TIA and TCD examination was 53 ± 49 days (range 1-207). To 
address the value of TCD in diagnosing stroke subtype, 120 patients were included, of which 56 
had had a lacunar infarction on CT. None of the patients with a non-lacunar infarction had MES 
on TCD (Table 4). Thus, sensitivity for stroke subtype was 0, specificity was 0.91.
TO address the value of TCD in diagnosing PCSE, 149 patients were included. Five patients 
had a cardiac source of embolism, and five patients had MES, none of which had a PCSE. Sen-
sitivity for PCSE was 0, specificity was 0.95 (Table 4). These data are indicated by the asterisk in 
Figure 1 and 2.
Discussion
In this systematic review, we studied the value of MES monitoring in the diagnosis of non-
lacunar infarcts or a PCSE in patients with a recent TIA or minor stroke. We used the summary 
ROC curve proposed by Moses et al.11 The comparison of the studies was hampered by the 
differences in TCD settings, and by the differences in the criteria for stroke subtype and PCSE 
between the studies. However, our results indicate that TCD could be a useful test to distinguish 
non-small-vessel disease from small vessel disease. The sensitivity for non-small vessel disease 
was 0.76, and specificity was 0.90, in the subgroup of studies that used a robust reference test.
For PCSE, TCD does not seem to be able to adequately distinguish between the presence 
and the absence of a PCSE. Sensitivity was low in all studies described in this review. The 
sensitivity at the optimal point on the sROC curve in the studies with a robust reference test 
was reasonable (0.74), but outside the predefined range of interest. No data were available in 
that part of the sROC curve, and therefore any point on the sROC curve outside the range of 
interest is not meaningful. Moreover, in two of the five studies with a robust reference test it 
was not clear whether patients with mechanical prosthetic heart valves were included or not. 
These patients usually have more frequent MES and MES of higher intensity because their MES 
probably do not reflect solid particles but cavitation bubbles.28,29 This may therefore influence 
the sensitivity and specificity of TCD for the presence of a PCSE.
In the Rotterdam TCD study no patients with a non-lacunar infarction had MES. Moreover, 
no patients with a PCSE had MES. The very low frequency of MES in our study could be related 
to the relatively long time interval between event and TCD investigation.
Our systematic review provides an estimate of the accuracy of TCD in the diagnosis of PCSE 
and ischemic stroke subtype. Data can be viewed in ROC space, and the trade-off between 
sensitivity and specificity is made clear.
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Limitations
Study populations in this type of analyses are often highly selected, but in our review this is 
unlikely: most studies involved consecutive patients, and in most studies the percentage of 
PCSE was not abnormally high (range 3 to 70%). Because of the differences in design between 
the studies, we cannot determine or quantify the contribution of each separate factor on 
diagnostic accuracy.
Only few studies reported a detailed description of the technical aspects of the MES detec-
tion, which were recommended by the International Consensus Committee on Microembolus 
Detection. More than half of the studies were published before the publication of the con-
sensus on microembolus detection.8 Reporting all 14 parameters suggested by the Consensus 
Committee may lead to redundancy, but the parameters such as ultrasound device, insonated 
artery, insonated depth, method of intensity measurement, decibel threshold, sample volume, 
FFT size, and FFT overlap have a high face validity. For example, only four studies3,10,19,20 gave a 
detailed description of intensity measurement of the ultrasound signal and this varied between 
those studies. Since intensity of MES is dependent on the method of intensity measurement, 
MES counted in one study might not have reached the decibel threshold in another study. 
This is especially important in patients in whom only one or two MES were counted. Moreover, 
because of these reported and unreported differences, the employed detection threshold is 
not directly comparable between the studies.
Our analysis did not include studies which used TCD and contrast agents to detect a patent 
formane ovale, since these studies were mainly different in study design. Direct comparison 
of these studies with the selected studies was not possible. Moreover, patent foramen ovale 
is a low risk PCSE, and medical and percutaneous treatment options are still under evaluation.
other studies
As far as we know, no systematic review of the diagnostic value of TCD in patients with a TIA 
or minor stroke has been carried out. The direct influence of variation in TCD-parameters such 
as detection threshold, duration of the investigation, and parameters related to the sampling 
method on diagnostic accuracy, could not be analysed on the basis of the reported data. ROC 
analysis in a single large study would be the method of choice to assess the effect of changing 
the dB threshold for MES detection, and perhaps, the added value of a human observer versus 
automated detection.
One other application of TCD in patients with a minor stroke or TIA that has not been stud-
ied sufficiently, is its potential in predicting long term outcome and recurrent strokes. In our 
opinion, this has to be studied in a large cohort of patients with adequate follow up. This will 
have to be studied with unambiguous criteria that can be duplicated in other TCD laboratories.
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Final conclusions and clinical relevance
The sensitivity and specificity for PCSE of MES detection with transcranial Doppler ultrasound is 
not high enough to recommend its use for screening prior to more invasive diagnostic investi-
gations, such as transesophageal echocardiography.
The sensitivity and specificity for non-lacunar stroke of MES detection with transcranial 
Doppler ultrasound in the diagnosis of non-lacunar stroke is of a more acceptable level. Its 
high specificity suggests that in patients with a very recent stroke a confident diagnosis of non-
lacunar stroke can be made, when MES are detected with TCD. Even though MES detection 
seems to be of limited diagnostic value in determining PCSE, it may be of use alongside other 
clinical information in determining stroke subtype in patients with TIAs, where history and 
other diagnostic information provides insufficient clues.
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AbstrAct
Background: In patients with a recent TIA or minor stroke, prediction of long term risk of major 
vascular events is important, but difficult. We aimed to study the external validity of currently 
available prediction models.
Methods: We validated predictions from 3 population-based models (Framingham, SCORE and 
INDIANA project) and 4 stroke-cohort-based models (SPI-II, Oxford TIA, Dutch TIA study, and 
the ABCD2 study) in an independent cohort of patients with a recent TIA or minor stroke.The 
validation cohort consisted of 592 patients with a TIA or minor stroke, with a mean follow-up 
of 2 years. The primary outcome was the two-year risk of the composite outcome event of non-
fatal stroke, MI or vascular death. We used calibration graphs and c-statistics to evaluate the 7 
models.
Results: The two-year risk of the primary outcome event was 12%. Calibration was adequate for 
stroke-population based studies. After adjustment for baseline risk and for prevalence of risk 
factors, calibration was adequate for the Dutch TIA, the ABCD2, and SPI-II models. Discrimina-
tion ranged from 0.61 to 0.68.
Conclusions: Discrimination was poor for all currently available risk prediction models for 
patients with a recent TIA or minor stroke, indicating the need for stronger predictors. Clinical 
usefulness may be best for the ABCD2 model which had a limited number of easily obtainable 
variables, a reasonable c-statistic (0.64), and good calibration.
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introDuction
Patients with a recent stroke have an increased long-term risk of new cerebrovascular and 
cardiovascular events. Estimates of long term risk of cardiovascular and cerebrovascular events 
are important for patients who want to know their individual risk, and for treating physicians, 
because in patients with increased long-term risk, more expensive or more hazardous interven-
tions) could be worthwhile. Long term risk seems to be dependent on the uynderlying risk 
factors.1
In an American Heart Association (AHA) statement it was pointed out that validated predic-
tion models for long-term cardiovascular risk in patients with ischemic stroke or TIA were not 
available.2 The use of a population-based prediction model, i.e. the Framingham risk score,3 
was recommended, however, this model has not been evaluated and compared with other 
prediction models to predict long-term cerebrovascular and cardiovascular risk in clinical prac-
tice. Treatment recommendations based on predictive models have been published and are 
currently used for patients with a significant carotid artery stenosis and for patients with atrial 
fibrillation.4,5 For patients without AF or a carotid artery stenosis, more precise risk estimations 
are needed.6,7 For this purpose, we need a reliable prognostic model with good discrimination 
between patients who will have new events and those who do not.
The aim of the present study is to determine which prediction models are adequate for 
long-term risk estimation for cardiovascular or cerebrovascular events in TIA and minor stroke 
patients. We primarily focused on major vascular events, i.e. non-fatal stroke, myocardial infarc-
tion and vascular death, because these affect health status most and are the focus of interven-
tion studies. Secondarily, we considered fatal and non-fatal stroke.
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methoDs
selection of prediction models
We compared the external validity, i.e. calibration and discrimination, of 3 population-based 
models (the Framingham risk score for cardiovascular events,3 the Framingham risk score for 
stroke,8 SCORE,9 and the INDIANA project cardiovascular risk score10), and 4 stroke-cohort-
based models (SPI-II,11 the Oxford TIA,7 the Dutch TIA study12, and the ABCD2 score13), in an 
independent cohort of patients with a recent TIA or minor stroke (Table 1). All models were 
designed to predict long term outcomes, except for the ABCD2 score which predicts 90-day 
risk of stroke. The stroke-population based models were designed to predict events after TIA 
or stroke, the population-based models were designed to predict first ever stroke or cardio-
vascular events. These models were based on well-described large cohorts of patients with TIA 
or minor stroke, and had the relative risks of the predictors estimated in a multiple (logistic or 
proportional hazards) regression model. The models predicted stroke and other cardiovascular 
events.
The Stroke Prognosis Instrument I (SPI-I) was developed in a small cohort of patients with 
a recent stroke. Kernan et al created SPI-II by incorporating new predictive variables identified 
in a cohort of patients from the WEST study, and validated it in three cohorts of patients from 
several secondary prevention trials.11
Hankey et al. developed a prediction equation for recurrent vascular events, based on eight 
clinical prognostic factors from a cohort of 469 hospital-referred TIA patients.7 The prediction 
model was validated in cohorts of TIA patients from the Oxfordshire Community Stroke Project 
and the UK-TIA study.14
The Dutch TIA trial investigators developed a set of predictors of major vascular events and 
of stroke. Their prediction model was based on data of patients with a TIA or minor stroke, who 
entered a multicenter, randomized controlled clinical trial with a 2x2 factorial design, of high 
versus low dose aspirin and propanolol versus placebo.12,15
The ABCD2 score calculates the 2, 7, and 90 day stroke risk in TIA patients.13 This prediction 
model was based on TIA patients presenting within 1 day of onset of symptoms. We used the 
90-day risk score, since this was closest to the two-year risk calculated in the validation cohort.
The three other models were population based models which have been widely used to 
assess cardiovascular risk. For risk of major vascular events we used the Framingham risk score 
for cardiovascular events, published in 1998.3 This model is based on categorical variables. For 
risk of stroke, we used the Framingham risk score for stroke, published in 1994.8
The SCORE prediction model methodology differs slightly from the other models. Annual, 
age and sex-dependent rates of coronary and vascular event were estimated from the data 
in an accelerated failure time model (Weibull). This model made use of age as a measure of 
exposure time to risk rather than a risk factor. Estimates of mortality rates were based on obser-
vations in age-categories.9
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Pocock et al. published a prediction instrument based on data from 8 randomized controlled 
trials of antihypertensive treatment in asymptomatic individuals, the INDIANA project. They 
developed three separate models for overall cardiovascular mortality, fatal coronary heart 
disease and fatal stroke.10
Validation cohort
The validation cohort consisted of 592 consecutive patients included in the Rotterdam Transcra-
nial Doppler study.16 Patients were recruited in our hospital. This study was designed to evaluate 
the diagnostic and prognostic value of transcranial Doppler ultrasonography in patients with a 
recent TIA or minor ischemic stroke. Patients were 18 years and older and had the index event 
within the preceding 6 months. They were independent (a score of 3 or less on the modified 
Rankin scale),17 and the TIA or stroke was of presumed atherosclerotic origin; this implied that 
patients with a mechanical heart valve and a proven dissection were excluded. Patients with 
atrial fibrillation or a significant symptomatic carotid artery stenosis (>70% stenosis, NASCET 
criteria) were also excluded. Follow-up started at time of recruitment. The mean time between 
index event and recruitment was 51 ± 45 days. The mean follow-up in this study was 755 days 
or 2.1 years (interquartile range 0.9 to 3.1). The study population consisted of patients for whom 
no other treatment than risk factor modification and antiplatelet medication was available.
Procedure and definitions
The primary outcome was the composite end point of stroke, myocardial infarction and vascu-
lar death. The secondary outcome was the composite end point of fatal or non-fatal stroke. In 
the validation cohort, stroke was defined as a focal neurological deficit, resulting in disability for 
more than 24 hours, confirmed by a neurologist, with CT scan, if possible.
Myocardial infarction was defined as an episode of precordial chest pain accompanied by 
ECG evidence of recent infarction, and/or release of cardiac enzymes. Vascular death was death 
within 4 weeks after stroke or MI, or sudden death. Follow-up was done annually by telephone 
survey by an experienced nurse. If patients reported any hospital visits or any symptoms sug-
gesting a vascular event, their treating physician was contacted for further information or dis-
charge letters. In the validation cohort Kaplan-Meier analysis of survival was used to estimate 
the two-year risk of the primary and secondary outcome.
The validation procedure was similar for each prediction model. First we estimated the 
actual two-year risk of primary and secondary outcome events for each patient in the validation 
cohort using Kaplan-Meier survival analysis. For missing values, the mean value of a variable 
was imputed. We then calculated the two-year risk as predicted by the seven models. To do 
so we used the original prediction equations of each model. Each equation was adjusted for 
the mean overall risk and for the prevalence of risk factors in the validation cohort, as recom-
mended by several authors.18,19
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calibration and discrimination
Two aspects of validity were examined: calibration and discrimination. Calibration, or reliability, 
measures how closely predicted outcomes agree with actual outcomes. Discrimination refers 
to the ability to distinguish patients with different outcomes.20 The predicted probabilities of 
vascular events should be trustworthy (calibration) and extreme (discrimination).
Calibration-in–the-large reflects whether the overall outcome of the study cohort was close 
to the average predicted two-year risk from a model. We constructed calibration plots, in which 
observed two-year outcome was plotted against predicted two-year risk (using a Kaplan-Meier 
survival curve). We indicate outcome by quintiles of predicted probabilities. Calibration curves 
can be approximated by a regression line (or calibration line) with intercept (α) and slope (β). 
Well-calibrated models have α=0 and β=1. We calculated slopes for each prediction model. 
Discrimination was quantified with the concordance (c)-statistic.The c-statistic resembles the 
area under the ROC curve. A c-statistic of 1 implies a test with perfect sensitivity and specificity, 
while a value of 0.5 implies that the model predictions are no better than chance.20
resuLts
comparability of the cohorts
We first compared the distribution of prognostic factors in the seven derivation cohorts 
(Table 2). People in the population-based studies from the INDIANA project and Framingham 
were younger than patients in the stroke cohorts and by definition did not have a history of 
stroke or myocardial infarction. For the SCORE population, the mean age or age distribution 
was not stated. In this study, relatively young subjects had participated, and subjects aged 
40 to 60 were particularly well represented. In the Oxford TIA cohort, all patients had a TIA, 
and about one third had amaurosis fugax (Table 2). In the validation cohort 57 major vascular 
events occurred during follow-up, for a two-year risk of 12 %, and 41 fatal or non-fatal strokes, 
for a two year-risk of 9%.
Table 4 shows the observed the predicted two-year risk of stroke, myocardial infarction or 
vascular death, as well as fatal or non-fatal stroke. The SPI-II overestimated the risk for both out-
come events in patients with low risk and underestimated in patients with high risk, whereas 
Oxford TIA, the Dutch TIA trial, and ABCD2 score overestimated the risk for both outcome 
events (Figure 1).
Discrimination
Discrimination varied between 0.61 and 0.68 for the risk of stroke, myocardial infarction or 
vascular death, and between 0.58 and 0.65 for the risk of fatal or non-fatal stroke (Table 4). 
Discrimination was higher in the stroke-cohort-based studies than in the population-based 
studies, but remained below 0.70.
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table 2. Baseline characteristics of the seven prediction model cohorts and the validation cohort. Mean 
values are given, unless indicated otherwise. - indicates data not available; n.a. indicates not applicable.
Validation 
cohort
SPI-II Oxford 
TIA
Dutch 
TIA
ABCD2 Framing-
ham
SCORE INDIANA 
project
 N in study 592 525 469 3127 4809 5345 205178 47008
 Age (years) 62 - 62 65 70 49 - 55
 Age over 60 - - - - 77% - - -
 Age over 65 44% 73% - 53% - - -
 Age over 70 29% 57% 25% 34% - 5% -
 Male sex 60% 0% 68% 65% 47% 47% 57% 57%
Stroke characteristics
 TIA (not stroke) 54% 23% 100% 32% 100% n.a. n.a. n.a.
 Multiple attacks 20% - - 32% - n.a. n.a. n.a.
  Amaurosis fugax only 6% - 34% 6% - n.a. n.a. n.a.
Risk factors
 Previous stroke 21% 20% 0% 0% - 0% n.a. 1%
 Previous MI1 24% 24% 21% 10% - 0% n.a. 5%
 Diabetes mellitus 11% 31% 5% 8% 17% 4.6% - 3%
 Angina pectoris 9% 6% - 9% - 0%
 Current smoker 26% - 47% 44% - 39% 40%
 Total chol. (mmol/l) 5.7 - 6.7 - - 5.4 6.1
 LDL-chol. (mmol/l) 3.8 - - - - 3.5 - -
 HDL-chol. (mmol/l) 1.3 - - - - 1.3 1.4 -
 SBP (mmHg) 148 -2 - 158 - 1463 133 162
 DBP (mmHg) 86 - - 91 - 82 - -
 SBP > 140 mm Hg - - - - 69% - - -
 DBP > 90 mm Hg - - - - 30% - - -
 BMI (kg/m2) 26.2 - - - - 25.8 - -
* Any MI, by history or ECG.
† Severe hypertension (systolic BP>180 or diastolic BP>100 mHg) in 31 patients (6%).
‡ Median systolic and diastolic BP instead of means were reported in the Framingham study
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table 3: Estimated two-year risk in the validation and derivation cohorts*
Validation 
cohort
SPI-II Oxford 
TIA
Dutch 
TIA
ABCD2 * Framingham SCORE INDIANA
project
 Stroke 9% - 9% 7% 7% 0.5% - † -
 Stroke or death 13% 20% - - 9% 3% - † -
 MI 4% - 6% - - 3% 3.5%‡ 0.5%
  Stroke, MI or vasc death 12% - 14% 12% - 3% 5.7%
* estimated 90-day risk in the ABCD2 study
† Product limit estimates were available for all studies but SCORE.
‡ Cumulative risk at age 65
table 4. Calibration and discrimination of the seven prediction models.
A . Major vascular events
Calibration Discrimination*
Predicted two-year 
risk
Observed two-year risk Slope [95% CI] c-statistic [95% CI]
SPI-II 13 % 12 % 1.62 [ 0.57 – 2.66] 0.68 [ 0.61 - 0.75 ]
Oxford TIA 17 % 12 % 0.60 [ 0.32 – 0.88] 0.66 [ 0.58 - 0.74 ]
Dutch TIA 14 % 12 % 0.92 [-0.27 – 2.11] 0.64 [ 0.56 - 0.72 ]
ABCD2 14% 12% 0.68 [ 0.40 – 0.96] 0.64 [ 0.57 - 0.70 ]
Framingham 14 % 12 % 0.37 [-0.46 – 1.21] 0.64 [ 0.57 - 0.72 ]
SCORE 12 % 12 % 0.34 [-0.29 – 0.97] 0.61 [ 0.53 - 0.69 ]
INDIANA project 21 % 12 % 0.21 [-0.22 – 0.63] 0.61 [ 0.54 - 0.69 ]
* The nullhypothesis that all values were equal was rejected (p=0.02, χ2 =15,27, 6 d.f.)
b . For stroke
Calibration Discrimination*
Predicted two-year 
risk
Observed two-year risk Slope [95% CI] c-statistic [95% CI]
SPI-II 10 % 9 % 1.12 [ 0.24 – 1.99] 0.64 [ 0.56 - 0.72 ]
Oxford TIA 13 % 9 % 0.47 [ 0.22 – 0.72] 0.63 [ 0.54 - 0.72 ]
Dutch TIA 11 % 9 % 0.56 [ 0.13 – 0.99] 0.64 [ 0.57 - 0.72 ]
ABCD2 11 % 9 % 0.58 [ 0.09 – 1.07] 0.61 [ 0.53 – 0.69 ]
Framingham 10 % 9 % 0.44 [-0.08 – 0.97] 0.58 [ 0.50 - 0.68 ]
SCORE 9 % 9 % 0.25 [-0.21 – 0.71] 0.58 [ 0.49 - 0.68 ]
INDIANA project 16 % 9 % 0.19 [-0.02 – 0.39] 0.61 [ 0.52 - 0.69 ]
* The 0 hypothesis that all areas were equal was not rejected (p=0.55, χ2 =4.93, 6 d.f.)
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Figure 1. Calibration graph. Mean predicted probabilities versus observed frequencies of the composite 
outcome event of A. non-fatal stroke, non-fatal myocardial infarction or vascular death, and B. Stroke (in 
quintiles).
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Discussion
This is the first study comparing the external validity of long term prediction models. In a scien-
tific statement for healthcare professionals from the Stroke Council and the Council on Clinical 
Cardiology of the American Heart Association/American Stroke Association, the Framingham 
study3 was recommended for long term cardiovascular risk in patients with a TIA or ischemic 
stroke.2 The purpose of our study was to find out whether stroke-cohort based studies indeed 
perform better and should be used in the future to estimate long term risk of major vascular 
events in patients with a TIA or ischemic stroke.
Calibration was fairly good in most models, but in the SPI-II study, the Dutch TIA study, and 
the ABCD2 study calibration was best. All models were adjusted for baseline risk and prevalence 
of risk factors as suggested by several authors.18,19 Without these adjustments calibration was 
poor. Overall, stroke-based prediction models from the Dutch TIA trial, the SPI-II study, and the 
ABCD2 study showed best calibration and discrimination. A clinically useful prediction model 
shows good calibration, discrimination and uses a limited number of clear-cut, easily available 
variables.
The ABCD2 score and the SCORE prediction model used the smallest number of variables in 
their prediction rule for long term cardiovascular risk, 5 and 6 respectively, and risk estimation 
derived from these studies is therefore easy to obtain. The Framingham prediction model for 
cerebrovascular risk included 8 factors, which are all easy to obtain except for left ventricular 
hypertrophy for which an ECG is needed. The Dutch TIA study used 17 variables in the predic-
tion rule. The Oxford TIA prediction rule and the INDIANA project prediction rule included ECG 
variables, which are more difficult to ascertain. The Dutch TIA prediction rule used ECG variables 
that require some expertise, such as left ventricular hyperthrophy by the Casale criteria,21 and 
anteroseptal infarction (Table 1), and included also CT scan variables. This makes these models 
less attractive to use.
Limitations of the study
Some limitations of this study have to be discussed. First, although the validation cohort was 
of reasonable size (592 patients), the effective sample size was not large, with 57 major events, 
and 41 fatal or non-fatal strokes. Second, predictions from all models, except for the ABCD2 
study, exceeded the two- year risk observed in our validation cohort. We have overcome this 
miscalibration by adjusting for this difference in follow-up in our analysis.
We excluded patients with AF or a severe carotid artery stenosis, and focussed on patients with 
TIA or minor ischemic stroke. This reduces the heterogeneity of the validation cohort, and may 
reduce the discriminatory ability of the models. Risk estimates are more readily available for 
carotid artery stenosis as well as for patients with AF. For the remaining group of patients with 
TIA or minor stroke there is a particular need for a prediction model.
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In the validation cohort as well as in two of the four stroke cohorts, the mean age was rather 
low (Table 2). These cohorts consisted of a hospital population. Hospital populations tend to be 
of lower age. They may therefore not be representative of patients with TIAs and minor strokes 
in the community.
The time between index event and recruitment in the validation cohort was 51 days, which 
differs substantially from the ABCD2 study, not the remaining stroke-based population studies. 
We have overcome this problem by adjusting for the baseline risk in all validation studies. In 
this way, we adjusted for the low number of outcome events compared to the ABCD2 study.
Validity
Although this was a study on long term risk, we also included the ABCD2 model, which was 
developed for estimation of short term risk. Calibration and discrimination in the ABCD2 study, 
however, did not differ substantially from the long term prediction models. Comparisons with 
other studies cannot be made, because similar studies of long term risk assessment in patients 
with TIA or ischemic are not available.
Possible improvements
The seven models used dichotomized variables instead of continuous variables. Perhaps with 
continuous variables estimations of risk would have been more precise and discrimination may 
improve.22 Furthermore, the stroke based prediction models were derived from trial popula-
tions with certain in- and exclusion criteria. The best fitting model for everyday practice will 
probably be derived from a representative cohort; this means a consecutive stroke population 
without exclusion criteria.
conclusion
Current prediction models for long term prognosis in TIA and stroke patients have limited valid-
ity. Calibration seems to be adequate for most models, but especially discrimination between 
high risk patients and low risk patients is relatively poor. Improvements such as implementation 
of continuous variables are needed, as well as extension with stronger predictors of outcome. 
For now, the SPI-II and the ABCD2 prediction models seem to be most adequate. Of these two, 
the ABCD2 may be preferred because of its easy applicability in clinical practice. 
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chapter 3.2
The prognostic value of pulsatility index, flow 
velocity, and their ratio, measured with TCD 
ultrasound, in patients with a recent TIA or 
ischemic stroke.
A.D. Wijnhoud
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AbstrAct
Background: Increased flow velocities, and combinations of low mean flow velocity (MFV) and 
a high pulsatility index (PI) are associated with intracranial arterial disease. We investigated the 
association of MFV and the ratio of PI and MFV (PI-MFV ratio) in the middle cerebral artery with 
recurrence of vascular events in patients with a TIA or minor ischemic stroke.
Methods: 598 consecutive patients underwent TCD-investigation. Outcome events were fatal 
or non-fatal stroke, and the composite of stroke, myocardial infarction or vascular death (major 
vascular events). Hazard ratio’s (HR) were estimated with Cox proportional hazards multiple 
regression method, adjusted for age, gender and vascular risk factors.
Results: TCD registration was successful in 489 patients. Mean follow-up was 2.1 years. Cumula-
tive incidence was 9% for all stroke, and 12% for major vascular events. MFV over 60.5 cm/s 
increased the risk both for stroke (HR 2.8; 95%CI: 1.3-6.0) and major vascular events (HR 2.6; 
95%CI: 1.3-5.0). Each unit increase in PI-MFV ratio was associated with a HR 2.8 (95%CI: 1.7-4.8) 
for stroke and HR 2.2 (95%CI: 1.3-3.6) for major vascular events.
Conclusion: In patients with a TIA or non-disabling ischemic stroke, MFV and the PI-MFV ratio 
in the middle cerebral artery are independent prognostic factors for recurrent vascular events.
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introDuction
Transcranial Doppler ultrasound investigation of the intracranial arteries in patients with a 
recent stroke or TIA may provide prognostic information in addition to conventional vascular 
risk factors. Increased flow velocities in the middle cerebral artery (MCA) may indicate a local 
stenosis.1 Furthermore, increased flow velocities in the MCA have been shown to be strongly 
related to vascular risk factors: flow velocities increase with hypertension, hypercholesterol-
emia, and in patients with diabetes mellitus.2 This suggests that increased flow velocities may 
be related to extra- and intracranial vascular disease. On the other hand, the combination of 
low mean flow velocity (MFV) and a high pulsatility index (PI) has been associated with diffuse 
stenosis of intracranial arteries in patients with stroke.3 Flow velocities however, decrease with 
increasing age and male gender.4,5 Because of these associations, unadjusted flow-velocities 
are difficult to interpret. We analysed the prognostic value of TCD- flow-parameters for recur-
rent stroke and other vascular events in a consecutive cohort of patients with a recent TIA or 
minor stroke.
methoDs
Patients
We studied patients from a prospective cohort study that investigated the diagnostic and 
prognostic value of TCD in patients with a recent TIA or ischemic non-disabling stroke.[2] In 
brief, inclusion criteria were a recent (<6 months) TIA or non-disabling ischemic stroke of pre-
sumed arterial origin. Patients had to be over 18 years of age, and had to give informed consent. 
Patients had to be independent in most activities of daily living, corresponding with grade 3 or 
better on the modified Rankin scale.6,7 We excluded patients with planned carotid surgery or 
stenting, because both TCD parameters and risk of recurrent events would be affected by the 
treatment. We also excluded patients with mechanical heart valves.
The study was approved by the Medical Ethics Committee and Review Board of the Erasmus 
MC in Rotterdam, the Netherlands.
tcD recordings
All patients underwent TCD examination (Multidop X-4, DWL, Sipplingen, Germany). All TCD 
recordings were carried out by one investigator (A.W.). TCD examination was performed within 
6 months after TIA or non-disabling ischemic stroke. In all patients, peak systolic flow velocity 
(PSV) and end-diastolic flow velocity (EDV) was measured with a handheld 2 MHz probe in both 
middle cerebral arteries (MCA). Mean flow velocity (MFV) was calculated as EDV + 1/3(PSV-EDV). 
The pulsatility index (PI) was calculated as (PSV-EDV)/MFV. Because of the expected interaction 
between PI and MFV, we created a new parameter the PI-MFV ratio, calculated as 100xPI/MFV. 
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In a note we added that the multpiplication by 100 is just for practical reasons. The mean of 
the above mentioned TCD parameters was calculated as the mean of both left and right sided 
measurements. In case of unilateral window failure, the contralateral parameter was taken as 
the mean.
Blood pressure was measured automatically with a self-inflating cuff (Dynamap, Datascope, 
The Netherlands) during TCD investigation. Pulse pressure was calculated as systolic blood 
pressure minus diastolic pressure.
Ancillary investigations
All patients underwent routine workup including neurological examination, a CT scan to rule 
out hemorrhage, and an ECG. These investigations were performed on admission or first visit to 
the outpatient clinic, always before the TCD investigation. Risk factors (diabetes mellitus, smok-
ing, hypertension, increased serum cholesterol level) were assessed as described previously.2 
A duplex-ultrasound scan of the carotid arteries was made in all patients with an anterior 
circulation stroke. Echocardiography was done in patients with a history of cardiac disease, 
abnormalities on ECG, or a cardiac bruit on physical examination.
outcome
Primary outcome event was all stroke, both fatal and non-fatal. Secondary outcome event 
was the composite of either non-fatal stroke, non-fatal myocardial infarction and death from 
all vascular causes, whichever occurred first. Tertiary outcome events were fatal or non-fatal 
ischemic stroke, or TIA. The definition of death from vascular causes included sudden death 
(unexpected death ocurring within one hour after onset of symptoms, or within 24 hours given 
circumstantial evidence) or death from stroke, ischemic heart disease, or peripheral vascular 
disease.
Follow-up was done annually by telephone survey by an experienced nurse. If patients 
reported any hospital visits or any symptoms suggesting a vascular event, their treating 
physician was contacted for further information or discharge letters. All outcome events were 
anonimized and next adjudicated by an experienced panel (A.W. and D.D.) without knowledge 
of the TCD findings.
statistical analysis
The cumulative probability of all outcome events was estimated with Kaplan-Meier survival 
analysis. The prognostic value of flow velocity parameters was analysed with Cox proportional 
hazards regression, and expressed as a hazard ratio (HR). Quintiles of TCD flow-parameters were 
used, because of non-normal distributions, and the lowest quintile was set als reference. For 
exploration of the relationship between the outcome events and the TCD flow velocity param-
eters, we used the upper quintiles of the TCD flow velocity parameters. Since PI-MFV ratio is 
an interaction factor it was analysed in a model including MFV and PI. In a note we added that 
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the multiplication by 100 is just for practical reasons. For exploration of the interaction factor 
PI-MFV ratio we included the variables MFV, PI, and PI-MFV ratio in the proportional hazards 
multipe regression model. Further adjustments for other vascular risk factors were also made 
with this method.
resuLts
clinical characteristics
We included 598 consecutive patients in our study. In 4 patients, the diagnosis was revised 
shortly after inclusion (1 patient had multiple sclerosis, 2 had focal epileptic seizures and 1 had 
migraine with aura). In 105 of the remaining 594 patients (17.7%), we failed to obtain adequate 
Doppler data due to two-sided window failure or other limitations.8 Therefore 489 patients 
were included in the present analysis. Mean age was 60 years, and two-thirds of the patients 
were men. Approximately half of the patients had transient symptoms; more than 75% had 
focal ischemia in the anterior circulation. Almost one third of the patients were current smokers, 
nearly half had hypertension and almost one sixth had diabetes mellitus (Table 1).
results of tcD examination
Mean time between TIA or stroke and TCD examination was 51 ± 45 days (range 1-207). In 22% 
of the patients TCD was performed within 2 weeks. Insonation depth varied from 48 to 56 mm. 
Mean MFV was 51.1 ± 14.4 cm/sec, mean PSV was 83.8 ± 22.1 cm/s, and mean EDV was 34.7 ± 
12.1 cm/s. Only four patients had a PSV higher than 155 cm/s, only one had a PSV higher than 
220 cm/s (223 cm/s).
The PI was 0.93 (SD 0.22). Mean PI-MFV ratio was 2.02 (SD 0.95). Nearly 25% of the patients 
had one-sided or double-sided window failure. Patients with window failure were older (71 
± 10 vs. 60 ± 13, p<0.001), were more often female (31% vs. 9%, p<0.001), and smoked less 
often (9% vs. 31%, p<0.001) than patients without window failure. MFV was lower in men, and 
MFV was negatively related to age, whereas diabetes and total serum cholesterol was positively 
related to MFV in this study, as described in a previous study of the same study population.2 
MFV was linearly related to PI, for every 10 cm/s increase in MFV, PI decreased with 0.05.
outcome events
Mean follow-up was two years and one month (range 17 days to 5.7 years). A recurrent TIA 
or stroke occurred in 64 patients. A major vascular event (stroke, myocardial infarction and 
vascular death) occurred in 60 patients (Table 2). The cumulative incidence was 9% (95% CI: 7 
to 12%) for fatal or non-fatal stroke, 12% (95% CI: 9 to 15%) for stroke, myocardial infarction or 
vascular death, and 14% (95% CI: 11 to 17%) for TIA, fatal or non-fatal ischemic stroke.
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table 1: Baseline patient characteristics.
Overall 
N=489
MFV£60.5cm/s 
N=393
MFV>60.5cm/s 
N=96
Demographics
Age, years (mean ± SD) 60 ± 13 62 ± 12 52 ± 13 p<0.0001
Male gender 323 (66%) 278 (71%) 45 (47%) p<0.0001
Caucasian race 410 (87%) 332 (87%) 78 (85%) NS
Stroke characteristics
TIA 261 (53%) 206 (52%) 55 (57%) NS
Anterior circulation 391 (80%) 318 (81%) 73 (76%) NS
Lacunar syndrome 180 (37%) 152 (39%) 28 (29%) P=0.083
CT characteristics
Any infarct on CT scan 225 (46%) 190 (48%) 35 (36%) P=0.036
White matter lesions on CT scan 62 (13%) 57 (15%) 5 (5%) P=0.014
Risk factors
Smoking, current 140 (29%) 107 (27%) 33 (34%) NS
Hypertension 259 (53%) 216 (55%) 43 (45%) P=0.073
Diabetes 77 (16%) 58 (15%) 19 (20%) NS
Previous TIA or stroke 106 (22%) 83 (21%) 23 (24%) NS
Previous myocardial infarction 53 (11%) 45 (12%) 8 (8%) NS
Carotid artery stenosis (≥70%) 37 (8%) 29 (7%) 8 (8%) NS
Body-mass-index, kg/m2 (mean ± SD) 26.1 ± 3.9 26.2 ± 3.8 25.9 ± 4.3 NS
Use of cholesterol lowering medication 123 (26%) 102 (27%) 21 (23%) NS
Cholesterol (mean ± SD)
Total cholesterol,mmol/l 5.7 ± 1.2 5.6 ± 1.1 6.1 ± 1.3 p<0.0001
HDL-cholesterol, mmol/l 1.3 ± 0.4 1.3 ± 0.4 1.4 ± 0.5 NS
LDL-cholesterol, mmol/l 3.8 ± 1.1 3.7 ± 1.0 4.1 ± 1.2 P=0.013
Cholesterol-HDL ratio 4.7 ± 1.6 4.7 ± 1.6 4.8 ± 1.7 NS
table 2: Occurrence of first outcome events
Outcome event N=489
Fatal or non-fatal stroke 39 (9%)
Stroke, myocardial infarction, or vascular death 57 (11.5%)
TIA or ischemic stroke 62 (12.5%)
TIA 31 (6%)
Non-fatal stroke 33 (7%)
Non-fatal myocardial infarction 6 (1%)
Vascular death 21 (4%)
Fatal stroke 8 (1.5%)
Fatal myocardial infarction 2 (0.5%)
Sudden death 10 (2%)
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Figure 1: Hazard ratio’s for quintiles of mean flow velocity for major vascular events (stroke, myocardial 
infarction, or vascular death) (upper graph), and for fatal or non-fatal stroke (lower graph), adjusted for 
age, gender, and vascular risk factors. Values on the x-axis are mean and range in each quintile.
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Mean flow velocity
The HR of MFV for fatal or non-fatal stroke, adjusted for age and gender, did not differ between 
the first four quintiles, but in the upper quintile the risk for major vascular events nearly doubled 
with a HR of 1.8 (95% CI 0.7 to 4.5) although this was not statistically significant. After adjust-
ment for vascular risk factors (diabetes, hypertension, cholesterol) the HR for fatal or non-fatal 
stroke did not change appreciably (HR 2.2, 95% CI 0.8 to 5.8) (Figure 1). Analyses with the MFV 
at the symptomatic side showed the same relationship, but this relationship was less strong.
Because the four lower quintiles of MFV showed similar risk, these were combined and a 
single cut point for the MFV was set at 60.5 cm/sec. Patients with an MFV>60.5 cm/s had a HR 
for fatal or non-fatal stroke of 2.8 (95% CI 1.3 to 6.0) after adjustment for age, gender, and vascu-
lar risk factors. HR for stroke, myocardial infarction or vascular death, was 2.6 (95% CI 1.3 to 5.0) 
for patients with an MFV>60.5 cm/s after adjustment for age, gender, and vascular risk factors 
(Table 3). MFV and PI did not show a statistically significant relationship with the outcome event 
TIA, fatal and non-fatal ischemic stroke.
Because of the possibility of increased risk with low flow, we did a more detailed analysis 
of the MFV in deciles. In the lowest decile of MFV the HR for fatal or non-fatal stroke was 10.9 
(95% CI: 1.3 to 88) compared to the decile with the lowest HR for fatal or non-fatal stroke (i.e. 
the second decile), adjusted for age, gender, and vascular risk factors. The median velocity in 
this decile was 33 cm/s (range: 18 to 36 cm/s). The HR in the 9th and 10th decile was 9.7 (95% 
table 3: Relationship between TCD flow parameters, occurrence of fatal or non-fatal stroke, major 
vascular events and stroke or TIA in a cohort of 489 patients with a TIA or non-disabling ischemic stroke. 
For EDV, MFV, PSV and PI HRs with 95% confidence intervals (95% CI) of the highest quintiles compared 
to the risk in the lower four quintiles combined are reported, adjusted for age, gender, and major vascular 
risk factors.
Fatal or non-fatal stroke Major vascular events Stroke or TIA
Mean flow velocity > 60.5 cm/s 2.8 (1.3 – 6.0) 2.6 (1.3 – 5.0) 1.7 (0.9 – 3.2)
Peak systolic flow velocity > 98 cm/s 2.3 (1.1 – 4.9) 2.1 (1.1 – 3.9) 1.7 (0.9 – 3.1)
End-diastolic flow velocity >43 cm/s 2.1 (0.9 – 4.8) 2.3 (1.1 – 4.8) 1.2 (0.6 – 2.5)
Pulsatility Index >1.09 1.5 (0.7 – 3.4) 1.4 (0.7 – 2.7) 1.6 (0.8 – 3.0)
table 4: Relationship between TCD flow parameters, occurrence of fatal or non-fatal stroke, major 
vascular events and stroke or TIA in a cohort of 489 patients with a TIA or non-disabling ischemic 
stroke. For PI-MFV ratio, MFV, and PI HRs with 95% confidence intervals (95% CI) of the highest quintiles 
compared to the risk in the lower four quintiles combined are reported, adjusted for age, gender, and 
major vascular risk factors.
Fatal or non-fatal stroke Major vascular events Stroke or TIA
PI-MFV ratio 2.5 (1.4 – 4.3) 1.9 (1.2 – 3.2) 2.3 (1.4 – 3.6)
Mean flow velocity 1.7 (1.3 – 2.0) 1.6 (1.3 – 1.9) 1.4 (1.2 – 1.7)
Pulsatility Index 0.8 (0.6 – 1.0) 0.8 (0.7 – 1.0) 0.8 (0.7 – 1.0)
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CI: 1.0 to 92) and 16.1 (95% CI: 1.9 to 140) respectively, again compared to the lowest decile. The 
lowest decile of MFV also showed an increased risk of major vascular events (HR 2.6, 95% CI: 0.9 
to 8.0), but this was not statistically significant.
PI-MFV ratio
The mean PI-MFV ratio was 2.01 (SD 0.95) and ranged from 0.46 to 8.25. Patients with a high 
PI-MFV ratio were older (67 ± 11 vs 55 ± 12 years, p<0.001), were more often male (75% vs 61%, 
p=0.001), and had more often hypertension (59% vs 49%, p=0.035). The HR for fatal or non-fatal 
stroke was 2.5 (95% CI: 1.4 to 4.3) for 1 unit increase in PI-MFV ratio, 1.7 (95% CI: 1.3 to 2.0) per 10 
m/s MFV, and 0.8 (95% CI: 0.6 to 1.0) per 0.1 unit of PI (Table 4) after adjustment for vascular risk 
factors. The HR for major vascular events was 1.9 (95% CI: 1.2 to 3.2) for 1 unit increase in PI-MFV 
ratio, 1.6 (95% CI: 1.3 to 1.9) per 10 m/s MFV, and 0.8 (95% CI: 0.7 to 1.0) per 0.1 unit of PI (Table 
4) after adjustment for vascular risk factors. The HR for TIA, fatal and non-fatal ischemic stroke 
was 2.3 (95% CI: 1.4 to 3.6) for 1 unit increase in PI-MFV, 1.4 (95% CI: 1.2 to 1.7) per 10 m/s MFV, 
and 0.8 (95% CI: 0.7 to 1.0) per 0.1 unit of PI (Table 4) after adjustment for vascular risk factors. 
Pulse pressure was not related to any of the outcome events, but it was associated with PI and 
PI-MFV ratio (correlation coefficient 0.51, p<0.00 and 0.34, p<0.00 respectively). Adjustment for 
pulse pressure did not change the hazard ratios for MFV, PI, and PI-MFV ratio.
Discussion
This cohort study of 489 patients with recent TIA or minor stroke shows that MFV and PI-MFV 
ratio, measured in the MCA by TCD are independent risk factors for recurrent stroke. Interest-
ingly, MFV and PI-MFV ratio were also associated with the occurrence of major vascular events 
(combined outcome measure “stroke, MI, and vascular death”). This suggests that the MFV and 
PI-MFV ratio reflect not only the condition of the major cerebral blood vessels, but also that of 
coronary and peripheral arteries.
Some methodological issues need to be discussed. In our study, one experienced investiga-
tor carried out all the TCD registrations, and all audiotapes were analysed by the same inves-
tigator. This excludes interobserver variability.9 We did not assess intra-observer variability, 
but previous studies have shown that intra-observer variability regarding Doppler ultrasound 
measurements is reasonable.10,11 Second, the MFV was a statistically significant risk factor only 
after adjustment for age, gender, and other vascular risk factors (hypertension, diabetes, and 
total serum cholesterol). This is probably caused by complex associations between these fac-
tors and outcome. For example, stroke risk increases with age, but when age increases, MFV 
decreases.2,4,12 This was also the case in our study. Third, the association between MFV and the 
occurrence of fatal and non-fatal stroke and major vascular events became statistically sig-
nificant after a dichotomization at the level of the fifth quintile. This observation was therefore 
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partly data-driven. Nevertheless, the association remained significant after alternative dichoto-
mization at the more usual cut point of 65 cm/sec. This dichotomization seems justified since 
the quintiles showed a pathophysiologically plausible J-shaped relationship with the outcome 
events. We did not adjust for several other vascular risk factors, most notably smoking and 
presence of vascular lesions on CT, because our previous study2 did not suggest a relationship 
between these factors and TCD parameters. Nevertheless, additional adjustment for these fac-
tors increased the risk ratios, and statistical significance. Fifth, in nearly 18% of our patients no 
adequate acoustical window could be obtained. These patients were predominantly elderly 
female patients. Although this proportion matches that of other studies,13,14 it implies that our 
findings are not representative for the entire hospital population of patients with recent TIA or 
stroke. Sixth, the majority of our patients underwent TCD several weeks after the index event, 
when the period of very high instantaneous risk of recurrent stroke has passed. However, time 
since onset of symptoms did not affect the HR for recurrent stroke or major vascular events in 
our study. Finally, we excluded patients with planned carotid surgery in our study, because after 
desobstruction of a symptomatic carotid stenosis, TCD findings will have changed and the risk 
for vascular events will be diminished.
In our study, the risk for fatal or non-fatal stroke nearly tripled at MFV > 60.5 cm/s, suggest-
ing that the elevated risk may perhaps be due to local MCA stenoses.15 MCA stenosis of more 
than 50% has been reported to be related to PSV1 and MFV.16,17. The risk of fatal or non-fatal 
stroke and major vascular events was most strongly related to MFV. However, intracranial 
atherosclerotic stenosis is an uncommon condition in Western Europe.16-19 Indeed, in only one 
patient (0.2%) MFV exceeded the 100 cm/sec cut point for an MCA stenosis of more than 50%. 
Because the negative predictive value of TCD in detecting intracranial arterial stenosis is high, 
94-100%,16,17 we can safely assume that the increased risk in the upper quintile of MFV is not 
caused by the presence of an MCA stenosis of more than 50%. Increased flow velocity may also 
be caused by hypertension, but we adjusted for this risk factor in our analyses.
The most likely explanation, however, is that the upper quintiles of MFV in our study repre-
sent a slight but uniform narrowing of the intracranial arteries. Bos et al., who reported similar 
findings in an elderly population, have argued that according to Poiseuille’s law small decreases 
in diameter of the arteries caused by atherosclerotic disease have to be compensated by 
relatively strong increases in blood flow.20 Increased flow itself may induce further endothelial 
damage of the smaller calibre intracranial arteries, followed by inflammatory response, lipid 
deposition and atherosclerotic plaque formation,21,22 especially in areas of low shear stress.23 
MFV may be a more reliable indicator of this process than PSV or systolic blood pressure. There-
fore, increased flow velocity could be a subtle marker for atherosclerosis.
The prognostic value of the PI-MFV ratio is a novel finding. Previous reports have shown a 
strong relationship between intracranial atheromatous disease and the combination of a high 
PI and a low MFV or PSV in intracerebral vessels measured by TCD.3,24 The PI, calculated as (PSV-
EDV)/MFV, is a complex parameter thought to reflect cerebrovascular resistance. Interestingly, 
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PI alone was not a prognostic factor for recurrent stroke. This may suggest that cerebrovascular 
resistance is only important when high cerebral blood flow cannot be maintained. A higher PI-
MFV ratio is thought to reflect diffuse intracranial stenotic disease, especially when MFV is lower 
than 30 cm/s, and PI is higher than 1.2.3 Prognosis of acute stroke (<12 hours) seems to be poor 
when MFV is lower than 30 cm/s.25 In our study the PI-MFV ratio was related to an increased 
risk of major vascular events (combined outcome measure “stroke, MI, and vascular death”). 
This may be explained by the presence of diffuse intracranial and extracranial atherosclerotic 
disease. A high PI-MFV ratio may indicate higher vulnerabiltiy of the brain in case of a thrombo-
embolic event with less or lower quality collateral flow. These explanations fall beyond the 
scope of the present analysis, but certainly deserve further study. Pulse pressure was associated 
with PI and also with PI-MFV ratio in our study. Nevertheless, even after adjustment for pulse 
pressure, the association between PI-MFV ratio and recurrent vascular events was not affected.
We further subdivided the population according to deciles of the MFV was divided in 
deciles. Our results then suggested a J or U-shaped relationship of MFV with the risk for recur-
rent stroke. Other physiological parameters are also known to have a U or J-shaped relationship 
with stroke and cardiovascular mortality. For example, low blood pressure as well as high blood 
pressure increase risk of stroke and cardiovascular mortality.26,27
We conclude that MFV and the PI-MFV ratio, measured with TCD is an independent prognostic 
factor for fatal or non-fatal stroke and major vascular events in patients with a recent TIA or 
minor stroke. These parameters may not only reflect the degree of local atherosclerosis of 
the cerebral arteries, but also of the general cardiovascular system. Our findings may help to 
improve the prediction of recurrent stroke and other vascular events in clinical practice.
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AbstrAct
Purpose: The prognostic value of micro-embolic signals (MES) on transcranial Doppler (TCD) 
ultrasound in patients with previous TIA or ischemic stroke and without significant carotid 
stenosis is unknown.
Methods: TCD-investigation was performed in a cohort of 365 patients with a recent TIA or 
ischemic stroke. The signal of the left and right middle cerebral artery (MCA) was recorded 
for 30 minutes and was stored on digital audio tape for off-line analysis. MES were defined 
according to the “Consensus on microembolus detection by TCD”. Outcome events were stroke 
and major vascular events (non-fatal stroke, non-fatal myocardial infarction or vascular death). 
Hazard ratio’s (HR) were estimated with Cox proportional hazards multiple regression method.
Results: Mean follow-up was 2.1 years. MES were observed in 16 (4%) patients. The occurrence 
of MES increased the risk of stroke, HR 3.8 (95% CI: 1.5 to 9.9), and the risk of ischemic stroke or 
TIA (HR: 2.6; 95% CI: 1.1 – 6.1). The HR for risk for major vascular events was 2.3; 95% CI: 0.9 –6.0).
Conclusion: In patients with a TIA or non-disabling ischemic stroke without severe carotid 
disease, MES in the MCA are rare. Nevertheless, in these patients, MES constitute a risk factor 
for recurrent stroke.
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introDuction
Detection of microembolic signals (MES) with transcranial Doppler ultrasound may provide 
prognostic information in addition to the conventional risk factors in patients with a TIA or 
minor stroke.1 In patients with symptomatic or asymptomatic carotid stenosis, MES are associ-
ated with an increased short-term risk of stroke or TIA.2,3 It is unknown whether these results 
apply to stroke patients without carotid artery stenosis.
We assessed the prognostic value of MES for recurrent stroke and other vascular events in a 
consecutive cohort of patients with a previous TIA or minor stroke.
methoDs
Patients
We studied the diagnostic and prognostic value of TCD in consecutive patients with a recent 
TIA or ischemic non-disabling stroke prospectively, from April 1999 until March 2003. Nearly 
all patients were included in our hospital, 22 were included in Meander Medisch centrum in 
Amersfoort. Inclusion criteria were a TIA or non-disabling ischemic stroke in the preceding 6 
months, corresponding with grade 3 or better on the modified Rankin scale.4 Patients had to be 
over 18 years of age, and had to give informed consent. We excluded patients in whom carotid 
surgery or stenting was planned. These patients were excluded because carotid artery stenosis 
is related to the presence of MES.{Molloy, 1999 25 /id} Patients with known atrial fibrillation, and 
patients with mechanical heart valves were also excluded, since in these patients MES occur 
frequently, and are thought to be gaseous, not solid.{Georgiadis, 1998 208 /id} The study was 
approved by the Medical Ethics Committee and Review Board of the Erasmus MC in Rotterdam, 
the Netherlands.
tcD recordings
All patients underwent TCD examination (Multidop X-4, DWL, Sipplingen, Germany). TCD 
examination was performed within 6 months after TIA or non-disabling ischemic stroke by 
one investigator (A.W.). The middle cerebral artery (MCA) was insonated bilaterally. For MES 
detection, the signal was recorded for 30 minutes and stored on digital audio tape (ADAT-LX20, 
Alesis, Santa Monica, California) for off-line analysis. This analysis was also performed by one 
investigator (A.W.), who was blinded to other clinical data and to the occurrence of outcome 
events, during off-line analysis. The intensity, depth and side of the MES were registered. MES 
were defined according to the Consensus on Microembolus Detection by TCD.5
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Ancillary investigations
All patients underwent routine workup including neurological examination, a CT scan to rule 
out hemorrhage, an ECG, and a duplex-ultrasound scan of the carotid arteries in case of an 
anterior circulation stroke. Risk factors (diabetes, smoking, hypertension, serum cholesterol 
level) were assessed as described previously.6
outcomes
The primary outcome event was fatal or non-fatal stroke (“stroke”). Secondary outcome events 
were the composite of non-fatal stroke, non-fatal myocardial infarction and death from all 
vascular causes (“major vascular events”), whichever occurred first.
Follow-up was done annually by telephone survey by an experienced nurse who was 
blinded for the TCD results. All possible events were adjudicated by two experienced vascular 
neurologists.
statistical analysis
The cumulative probability of composite outcome events was estimated with Kaplan-Meier 
survival analysis. Hazard ratios (HR) with 95% confidence intervals (CI) for MES were estimated 
with Cox proportional hazards regression.
resuLts
clinical characteristics
We included 598 consecutive patients in our study. In 4 patients, the diagnosis was revised 
shortly after inclusion. Exactly 105 of the remaining 594 patients had two-sided window failure. 
Because of technical problems or because they did not tolerate the headband, 124 patients 
did not complete the 30 minute registration. The remaining 365 patients were included in the 
present analysis (Table 1).
results of tcD examination
Mean time between index event and TCD examination was 53 ± 49 days (range 1-207), and 
did not differ between patients with MES and patients without MES (38 ± 43 vs 53 ± 48 days, 
p=0.21). MES occurred in 16 patients (4 %). The mean number of MES was 7 (range 1 to 37).
outcome events
Mean follow-up was 2.3 years (range 17 days to 5.7 years). The two-year cumulative incidence 
was 10% for stroke and 13% for major vascular events.
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micro-embolic signals
The risk for stroke was increased in patients with MES, HR 3.8 (95% CI: 1.5 to 9.9). The HR for 
major vascular events was 2.3 (95% CI: 0.9 to 6.0). The occurrence of MES was not related to time 
between TIA or stroke and TCD examination (Figure 1).
The risk for stroke was increased with the number of observed MES per patient, HR 1.11 (95% 
CI: 1.01 to 1.22 per single observed MES). Adjustment for age, gender, and vascular risk factors 
did not attenuate this association. One patient with a symptomatic carotid artery occlusion and 
an asymptomatic artery stenosis had 37 MES in 30 minutes on the asymptomatic side. Because 
this patient was initially not intended to undergo a carotid endarterectomy, we included him in 
the study. Exclusion of this patient did not change our results.
table 1: Patient characteristics.
Overall N=365 No MES N=349 MES N=16
Demographics
Age, years (mean ± SD) 59 ± 13 59 ± 13 59 ± 10 NS
Male gender 243 (67%) 229 (66%) 14 (88%) P=0.07
Caucasian 313 (87%) 298 (87%) 15 (94%) NS
Stroke characteristics
TIA 187 (51%) 179 (51%) 8 (50%) NS
Anterior circulation 286 (78%) 271 (78%) 15 (94%) NS
Lacunar syndrome 134 (36%) 124 (36%) 10 (63%) P=0.029
CT characteristics
Any infarct on CT scan 171 (47%) 163 (47%) 8 (50%) NS
White matter lesions on CT scan 52 (14%) 50 (14%) 2 (13%) NS
Risk factors
Smoking, current 100 (27%) 95 (27%) 5 (31%) NS
Hypertension 189 (52%) 182 (52%) 7 (44%) NS
Diabetes 53 (15%) 52 (15%) 1 (6%) NS
Previous TIA or stroke 83 (23%) 78 (23%) 5 (31%) NS
Previous myocardial infarction 45 (12%) 45 (13%) 0 (0%) NS
Carotid artery stenosis (≥70%) 25 (7%) 24 (7%) 1 (6%) NS
table 2: Relationship between MES and relative risk of fatal or non-fatal stroke, major vascular events, and 
stroke or TIA in a cohort of 365 patients with a TIA or non-disabling ischemic stroke.
Hazard ratio (95% Confidence Interval)
Fatal or non-fatal stroke 3.8 (1.5 – 9.7)
Major vascular events 2.3 (0.9 – 6.0)
Stroke or TIA 2.6 (1.1 – 6.1)
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Discussion
This study indicates that MES in the MCA measured by TCD increase the risk of stroke almost 
fourfold. MES were present in only 4% of the patients.
Some methodological issues need to be discussed. In our study, one experienced investiga-
tor carried out all the TCD registrations, and all tapes were analysed by the same investigator. 
This excludes interobserver variability. Second, 17.7% of our patients had a bilateral inadequate 
acoustical window. These patients were predominantly elderly female patients. Although this 
proportion matches that of other studies,7 it implies that our findings are not representative 
for the entire hospital population of patients with previous TIA or stroke. The majority of our 
patients underwent TCD several weeks after their TIA or stroke, that is, beyond the period with 
the highest risk of recurrent stroke. However, time since onset of symptoms did not affect the 
HR for recurrent stroke or major vascular events.
In the patients without a carotid artery stenosis or atrial fibrillation it is not clear what the 
origin of the MES is. However, MES constitute a risk factor for stroke and major vascular events, 
regardless of the origin.
Only 4% of our patients had MES. This low prevalence was not surprising since MES most 
frequently occur in patients with a carotid artery stenosis8 and we had excluded patients with a 
planned carotid surgery in our study, because after surgery for a symptomatic carotid stenosis, 
the risk of ischemic stroke diminishes, which would make our results more difficult to interpret.
MES most often occur in the acute phase after stroke,9 whereas our patients were predomi-
nantly examined in the subacute or chronic phase. Nevertheless, MES were still related to a 
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Figure 1: Number of patients with MES in relation to time from index event to TCD examination in a series 
of 365 patients with a TIA or ischemic stroke.
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recurrent fatal or non-fatal stroke. Idicula et al.10 showed that MES are frequent in acute stroke, 
with MES present in 25% of the patients. MES were, however, in the acute phase not related to 
a recurrent vascular event. It is therefore likely that the mechanism of MES is in the acute phase 
different from the chronic phase.
In patients with a carotid artery stenosis, either symptomatic or asymptomatic, MES were 
related to increased risk of ipsilateral stroke. As far as we know, this has not been investigated 
in an unselected series of patients with stroke until now. In our study, only one of the patients 
with MES had carotid artery stenosis, and leaving that patient out of the statistical analysis did 
not change the results.
We conclude that in patients with a TIA or non-disabling ischemic stroke, even in the absence 
of a carotid artery stenosis, MES constitute a risk factor for recurrent stroke.
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AbstrAct
Background: Prediction models are important for long-term vascular events in patients with 
a recent TIA or ischemic stroke. We aimed to study the incremental value of micro-embolic 
signals (MES) and flow velocity parameters measured with transcranial Doppler (TCD) over 
clinical variables alone in predicting recurrent vascular events.
Methods: The cohort consisted of 592 patients with a TIA or minor stroke, with a mean follow-up 
of 2 years. Mean flow velocity (MFV) could be measured in 489 of these patients in both middle 
cerebral arteries. Micro-embolic signals were recorded for 30 minutes and were analysed off-
line in 365 patients. Outcomes were the composite of non-fatal stroke, myocardial infarction or 
vascular death (Major vascular events) with a two-year risk of 13%, and the composite of fatal or 
non-fatal stroke (Stroke) with a two-year risk of 10%. We used calibration graphs, the c-statistic, 
and the Net Reclassification Index (NRI) to evaluate the effect of adding TCD parameters to the 
ABCD2 clinical prediction model.
Results: Adding MES and high mean flow velocity to the ABCD2 score improved the discrimina-
tion for both models, with increasing c-statistic from 0.62 to 0.69 (p<001) for major vascular 
events, and from 0.61 to 0.71 (p<0.01) for fatal or non-fatal stroke. The NRI was 0.31 (95% CI 0.01 
to 0.60) for prediction of major vascular events, and 0.42 (0.07 to 0.77) for prediction of fatal or 
non-fatal stroke.
Conclusion: Information concerning micro-embolic signals and mean flow velocity on TCD 
modestly improves the prediction of models for the recurrence of fatal or non-fatal stroke. 
Further studies are necessary on the validity and clinical application of these models.
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introDuction
Patients with a recent stroke have an increased long-term risk of new cerebrovascular and 
cardiovascular events. In a previous study, we showed that the ABCD2 prediction model is most 
useful compared to other available models for prediction of long term risk in these patients. 
However, the discrimination between patients with high and low risk of recurrent stroke could 
be much improved.1 Micro-embolic signals and flow velocity parameters measured with tran-
scranial Doppler ultrasonography are prognostic factors for cerebrovascular and cardiovascular 
events in patients with a recent TIA or ischemic stroke with2 and without3 carotid artery steno-
sis. The prognostic value of MES or the flow velocity parameters measured with TCD have not 
yet been studied in a long-term prediction model.
methoDs
We studied patients from a prospective cohort study of the diagnostic and prognostic value of 
TCD in patients with a recent TIA or ischemic non-disabling stroke as described in a previous 
study.[2] In brief, inclusion criteria were a recent (<6 months) TIA or non-disabling ischemic 
stroke of presumed arterial origin. Patients had to be over 18 years of age, and had to give 
informed consent. Patients had to be independent in most activities of daily living, correspond-
ing with grade 3 or better on the modified Rankin scale.4 We excluded patients with planned 
carotid surgery or stenting, because the risk of recurrent events would be affected by the treat-
ment. For similar reasons, we excluded patients with mechanical heart valves. The study was 
approved by our Medical Ethics Committee and Review Board.
Procedure and definitions
The primary outcome was the composite end point of stroke, myocardial infarction and vascu-
lar death. The secondary outcome was the composite end point of fatal or non-fatal stroke. In 
the validation cohort, stroke was defined as a focal neurological deficit, resulting in disability for 
more than 24 hours, confirmed by a neurologist, with CT scan, if possible.
Myocardial infarction was defined as an episode of precordial chest pain accompanied 
by ECG evidence of recent infarction, and/or release of cardiac enzymes. Vascular death was 
death within 4 weeks after stroke or MI, or sudden death. Follow-up was done annually by 
telephone survey by an experienced research nurse. If patients reported any hospital visits or 
any symptoms suggesting a vascular event, their treating physician was contacted for further 
information or discharge letters. In the validation cohort Kaplan-Meier analysis of survival was 
used to estimate the two-year risk of the primary and secondary outcome.
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tcD recordings
All patients underwent TCD examination (Multidop X-4, DWL, Sipplingen, Germany). All TCD 
recordings were carried out by one investigator (A.W.). TCD examination was performed within 
6 months after TIA or non-disabling ischemic stroke. In all patients, peak systolic flow veloc-
ity (PSV) and end-diastolic flow velocity (EDV) was measured with a handheld 2 MHz probe 
in both middle cerebral arteries (MCA). Mean flow velocity (MFV) was calculated as EDV + 
1/3(PSV-EDV). For MES detection, the signal was recorded for 30 minutes and stored on digital 
audio tape (ADAT-LX20, Alesis, Santa Monica, California) for off-line analysis. This analysis was 
also performed by one investigator (A.W.), who was blinded to other clinical data and to the 
occurrence of outcome events. During off-line analysis, the intensity, depth and side of the MES 
were registered. MES had to meet the following criteria: MES are transient, last less than 300 
milliseconds, are unidirectional within the Doppler velocity spectrum, are accompanied by a 
“snap”, “chirp”, or “moan” on the audible output and their amplitude is at least 3 dB higher than 
that of the background blood flow velocity spectrum.5
statistical analysis
MFV was dichotomized at 60.5 cm/s since MFV > 60.5 cm/s increases risk of major vascular 
events and stroke in patients with a TIA or ischemic stroke.3 We estimated the actual two-year 
risk of primary and secondary outcome events for each patient in the validation cohort using 
Kaplan-Meier survival analysis. For missing values, the mean value of a variable was imputed. 
We then calculated the two-year risk as predicted by the ABCD2 prediction model in a Cox’s 
proportional hazard model The equation was adjusted for the mean cumulative hazard and for 
the prevalence of risk factors in the validation cohort, as recommended by several authors.6,7 
We then added the TCD parameters MES and MFV>60.5 cm/s to this model.
calibration and discrimination
Two aspects of validity were examined: calibration and discrimination. Calibration, measures 
how closely predicted outcomes agree with actual outcomes. Discrimination refers to the 
ability to distinguish patients who will have an outcome event and those who will not.8 The 
predicted probabilities of vascular events should be trustworthy (calibration) and extreme 
(discrimination).
We constructed calibration plots, in which observed two-year outcome was plotted against 
predicted two-year risk, using a Kaplan-Meier survival curve and the ABCD2 prediction rule, 
with and without the TCD parameters. We indicate outcome by quintiles of predicted prob-
abilities. Calibration curves can be approximated by a regression line (or calibration line) with 
intercept (α) and slope (β). Well-calibrated models have α=0 and β=1. We calculated slopes for 
each prediction model. Discrimination was quantified with the concordance (c)-statistic, taking 
censored observations into account. The c-statistic resembles the area under the ROC curve. A 
c-statistic of 1 implies a test with perfect sensitivity and specificity, while a value of 0.5 implies 
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that the model predictions are no better than chance.8 Statistical significance of improvements 
of the model was analysed by chi square analysis of the log likelihood ratio, with appropriate 
degrees of freedom. We also calculated the Net Reclassification Index (NRI). The NRI measures 
the proportion of patients with an improved prediction minus the proportion of patients with 
a worse prediction after adding the TCD parameters to the ABCD2 model. A positive NRI means 
improvement of the model.
resuLts
clinical characteristics
We included 598 consecutive patients in our study. The study population consisted of patients 
for whom no other treatment than risk factor modification and antiplatelet medication was 
available. In 4 patients, the diagnosis was revised shortly after inclusion (1 patient had multiple 
sclerosis, 2 had focal epileptic seizures and 1 had migraine with aura). In 105 (17.8%) of the 
remaining 594 patients, we failed to obtain adequate Doppler data due to two-sided window 
failure. Therefore, in 489 patients (82.2%) we obtained adequate data for flow velocity measure-
ments (i.e. mean flow velocity). A total of 114 (19%) did not complete the 30 minute registration 
because of technical problems or because they did not tolerate the headband. The remaining 
365 patients (61.5%) were included in the analysis of MES. The baseline characteristics are 
described in Table 1.
results of tcD examination
Mean time between index event and TCD examination was 53 ± 49 days (range 1-207), and 
did not differ between patients with MES and patients without MES (38 ± 43 vs 53 ± 48 days, 
p=0.21). MES occurred in 16 patients (4 %). The mean number of MES was 7 (range 1 to 37). 
Mean MFV was 51.1 ± 14.4 cm/sec. MFV was negatively related to age, and was lower in men, 
whereas diabetes and total serum cholesterol was positively related to MFV in this study, as 
described in a previous study of the same study population.9
outcome events
Mean follow-up was two years and one month (range 17 days to 5.7 years). Two-year-risk was 
13% for major vascular events and 10% for fatal or non-fatal stroke.
calibration and discrimination
The ABCD2 prediction model overestimated the risk of recurrent vascular events (Table 2 and 
Fig 1). Adding MES improved calibration of the model (p=0.036), but not discrimination for 
major vascular events (Table 2). Adding MES to the prediction model for stroke improved the 
model (p=0.03), and also improved discrimination (delta c=0.04, p<0.02). Adding MFV>60.5 
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table 1: Patient characteristics.
Patients All N=594 With successful TCD registration N=365
Demographics
Age, years (mean ± SD) 62 ± 13 59 ± 13
Male gender 353 (59%) 243 (67%)
Caucasian 495 (83) 313 (87%)
Stroke characteristics
TIA 322 (54%) 187 (51%)
Anterior circulation 477 (80%) 286 (78%)
Lacunar syndrome 214 (36%) 134 (36%)
CT characteristics
Any infarct on CT scan 276 (46%) 171 (47%)
White matter lesions (CT) 91 (15%) 52 (14%)
Risk factors
Smoking, current 155 (26%) 100 (27%)
Hypertension 312 (53%) 189 (52%)
Diabetes 99 (17%) 53 (15%)
Previous TIA or stroke 123 (21%) 83 (23%)
Previous myocardial infarction 62 (10%) 45 (12%)
Carotid artery stenosis (≥70%) 44 (7%) 25 (7%)
table 2. Effect of adding MES, MFV>60.5 cm/s, and both to ABCD2 prediction model in patients with 
successful TCD registration (n=365).
Calibration Discrimination
NRI
Slope [95% CI] c-statistic [95% CI]
Major vascular events
 ABCD2 alone 0.88 [0.04–1.17] 0.62 [0.54–0.70 ]
 Model including MES 1.16 [0.5–1.76] 0.66 [0.58–0.74] 0.12 [-0.17–0.42]
 Model including MFV>60.5 cm/s 1.15 [0.60–1.70] 0.64 [0.57–0.72 ] 0.21 [-0.08–0.51]
 Model including MES and MFV>60.5 cm/s 1.25 [0.57–1.94] 0.69 [0.61–0.76 ] 0.31 [0.01–0.60]
Stroke
 ABCD2 alone 0.82 [-0.43–2.07] 0.61 [0.52–0.71]
 Model including MES 1.26 [0.67–1.86] 0.66 [0.57–0.75 ] 0.21 [-0.13–0.59]
 Model including MFV>60.5 cm/s 1.03 [0.36–1.70] 0.65 [0.57–0.73 ] 0.25 [-0.10–0.60]
 Model including MES and MFV>60.5 cm/s 1.04 [0.29–1.78] 0.71 [0.62–0.80 ] 0.42 [0.07–0.77]
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cm/s to the ABCD2 improved the model, but just not significantly (p=0.054) for major vascular 
events. Discrimination however, improved (p<0.02). Adding MFV>60 cm/s improved the model 
for stroke, but not significantly (p=0.079).
When both MES and MFV>60.5 cm/s were added to the ABCD2 prediction model using 
the prognostic sum score, both parameters improved of the model for major vascular events 
(p=0.037 for MES, and p=0.021 for MFV>60.5 cm/s. HR for the presence of MES in this model 
was 2.67 (95% CI: 1.06 to 6.73), and HR for MFV>60.5 cm/s was 2.04 (95% CI: 1.11 to 3.74) for 
the outcome event major vascular events. Discrimination improved from 0.62 to 0.69 (p<0.01). 
The NRI was positive, 0.31 (0.01-0.60), which means a significiant improvement of the model. 
Both MES and MFV improved the model for stroke (p=0.003 for MES, and p=0.029 for MFV>60.5 
cm/s). For the outcome event fatal or non-fatal stroke, the HR for MES was 4.21 (95% CI: 1.63 to 
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Figure 1. Calibration graph: Mean predicted probabilities (X-axis) versus observed frequencies (Y-axis) of 
the composite outcome event of non-fatal stroke, non-fatal myocardial infarction or vascular death (A) 
based on ABCD2 score with and without TCD parameters, of the composite outcome event fatal or non-
fatal stroke (B) based on the ABCD2 score with and without MES and MFV>60.5 cm/s.
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10.87), the HR for MFV>60.5 cm/s was 2.23 (95% CI: 1.08 to 4.57). Discrimination improved from 
0.61 to 0.71 (p<0.01). The NRI was again positive, 0.42 (0.07-0.77).
Discussion
This study shows that MES and a MFV> 60.5 cm/s in the MCA are independent prognostic fac-
tors for long term prognosis in patients with a recent TIA or minor ischemic stroke when added 
to the ABCD2 prediction model. Moreover, adding these two factors to the ABCD2 prediction 
model improves calibration as well as discrimination. For a 70-yr old patient with hypertension 
but no diabetes, and a hemiparesis lasting longer than 60 minutes, the two-year risk would be 
14%, for the same patient with MES and a MFV>60 cm/s in the MCA the two-year risk would be 
28%, without MES and increased MFV, his two-year risk would amount to 19%.
Some limitations of this study have to be discussed. First, although the validation cohort 
was of reasonable size (598 patients), the effective sample size was not large, with 57 major 
vascular events, and 41 fatal or non-fatal strokes. Because of window failure and intolerance 
to the headband, not all patients were included in the final analyses which made the effective 
sample size even smaller. Our validation cohort was also our derivation cohort. This influences 
calibration, which is usually better based on the derivation cohort instead of an independent 
sample. It will be very interesting to see if our results can be replicated in other studies.
Although the ABCD2 prediction model was intended for short-term prognosis, external 
validation of the ABCD2 score shows reasonable calibration and discrimination.1 Holzer et al. 
demonstrated that an ABCD2 score > 3 was associated with an increased risk for vascular events 
for medium- to long-term prognosis.10
TCD parameters have not been added to the ABCD2 score to improve prediction of stroke or 
other vascular events before. Adding brain infarction or carotid imaging to the ABCD2 model 
improves the prediction of stroke after TIA in the acute phase.11,12 However, for long-term 
prognosis of the ABCD2 score no attempts of improvement have yet been made.
Conclusion: MES and MFV>60.5 cm/s improve prediction of recurrent vascular events in 
patients with a TIA or minor ischemic stroke when added to the ABCD2 prediction model.
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In this thesis, I have studied the value of transcranial Doppler ultrasonography (TCD) in patients 
with a recent TIA or ischemic stroke. In this Chapter, I will summarize the main findings, discuss 
methodological issues, review the results in the broader perspective of their clinical application 
and discuss their clinical relevance. Finally, I will provide suggestions for further research.
My research questions were:
1. Can TCD be of diagnostic value in detetecting the presence of a potential cardiac source of 
embolism and small vessel disease in patients with a TIA or minor ischemic stroke?
2. Is it possible to identify patients with a high risk of recurrent vascular events after TIA or 
minor ischemic stroke by means of TCD investigation? If so, can TCD improve prediction 
models?
mAin FinDings
Diagnostic value of transcranial Doppler ultrasonography
I found that TCD parameters have a complex relationship with vascular risk factors such as age, 
hypertension and diabetes. I investigated these relationships, because these vascular risk fac-
tors may confound the association between TCD results and recurrent vascular events. 1-3 One 
of our main goals was to investigate if TCD parameters such as flow velocities can be of more 
diagnostic and prognostic value in predicting vascular outcome events than these vascular risk 
factors alone. In the patients participating in the study, blood flow velocity in the middle cere-
bral artery (MCA) decreased with age, and was lower in men than in women. Blood flow velocity 
in the MCA increased with total serum cholesterol, and was increased in diabetics compared 
to non-diabetics. Cerebrovascular CO2-reactivity was lower in hypertensive patients. Cerebral 
CO2-reactivity decreased with increasing total serum cholesterol (Chapter 2.1).
I found that micro-embolic signals (MES) were more often present in patients with a non-
lacunar stroke than in patients with a lacunar stroke. MES were more often present in the acute 
phase of TIA or ischemic stroke than in the chronic phase. MES could not discriminate between 
patients with and without a potential cardiac source of embolism (PCSE) (Chapter 2.3) which 
was one of the main questions of this thesis. In our large cohort of patients, MES were present 
in only 4% of the patients.
Prognostic value of transcranial Doppler ultrasonography
Mean Flow velocity
Mean flow velocity (MFV) in the MCA is an independent risk factor for recurrent stroke. I found 
that patients with an MFV of more than 60.5 cm/s (the upper quintile) had 3 times increased 
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risk of recurrent stroke or other major vascular events compared with the other patients. This 
relationship was not influenced by other vascular risk factors (Chapter 3.2).
PI-MFV ratio
MFV was related to pulsatility index (PI), which is a measure of peripheral vascular resistance. 
The PI is calculated as PSV-EDV/MFV. Our results showed that PI decreased strongly when MFV 
increased, and both were associated with recurrent stroke. Because of this interaction, I created 
a new factor, the PI-MFV ratio which is the PI divided by the MFV, and therefore ((PSV-EDV)/
MFV2). The PI-MFV ratio was clearly related to other vascular risk factors. Patients with a high 
PI-MFV ratio were older, were more often male, and had more often hypertension. But even 
after adjustment for these risk factors, which are potential confounders, the PI-MFV ratio was 
associated with a higher risk of recurrent stroke or other vascular events, even stronger than 
the PI (Chapter 3.2).
Micro-embolic signals
Patients with MES had an almost fourfold increased risk of stroke in my study population. This 
risk applied to patients without a carotid artery stenosis. More surprisingly, I found that patients 
with MES also had an increased risk of other major vascular events such as myocardial infarc-
tion or vascular death (Chapter 3.3). The prevalence of MES was low however, compared to the 
prevalence in patients with symptomatic carotid stenosis; MES were only present in 4% of the 
patients.
improvement of prediction
In order to improve prediction in patients with stroke and TIA, we first compared 7 prediction 
models to determine which provided the most adequate estimation of the long-term risk 
for cardiovascular or cerebrovascular events. I compared external validity, i.e. calibration and 
discrimination, of population based models and of stroke-cohort based models (Chapter 3.1). 
Calibration, or reliability, measures how closely predicted outcomes agree with actual out-
comes. Discrimination refers to the ability to distinguish patients with and without outcome 
events. Overall, we found that the ABCD2 study performed best and was most easily clinically 
applicable (Chapter 3.1). I therefore chose the ABCD2 study to evaluate whether prediction 
of long-term risk of patients with a TIA or minor stroke could be improved by adding TCD 
parameters.
The ABCD2 prediction model includes 5 parameters: Age, Blood pressure, Clinical features (i.e. 
aphasia, unilateral weakness, or other symptoms), Duration of the symptoms, and Diabetes. 
These parameters are easy to assess and this model is therefore very easy to use. This model 
was originally designed to predict short term risk: 2 days, 7 days, and 30 days. I found that 
this model was also applicable to predict recurrent stroke or other major vascular events in 2 
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years. This model performed better when the before mentioned TCD parameters were added 
(Chapter 3.4).
Adding the presence of MES as well as the upper quintile of MFV separately to the ABCD2 
prediction model improved both its calibration and discrimination, though not significantly. 
If both were added simultaneously calibration and discrimination for prediction of recurrent 
stroke and other vascular events were significantly improved (Chapter 3.4).
Discrimination measured by c-statistic improved from 0.62 to 0.69 (p<0.01) for major vascular 
events, and from 0.61 to 0.71 (p<0.01) for recurrent stroke. The Net Reclassification Index (NRI) 
was 0.31 (95% CI: 0.01 to 0.60) for the prediction of major vascular events. The NRI was 0.42 
(95% CI: 0.07 to 0.77) for the prediction of recurrent stroke (Chapter 3.4). The NRI measures the 
proportion of patients with an improved prediction minus the proportion of patients with a 
worse prediction after adding the TCD parameters to the ABCD2 model. A positive NRI means 
improvement of the prediction model.
Window failure
In my study, TCD registration was not successful in all patients. Nearly 18% of the patients had 
two-sided window failure (WF), e.g. the failure of the ultrasound signal to pass through the 
temporal bone. I found that age and female gender were strongly related to WF. The skull thick-
ness at the level of the temporal window was related to inadequacy of the ultrasound signal 
causing WF. A decreased radiodensity of the bone at the temporal window was also related to 
WF, but not significantly so, after adjustment for age and gender (Chapter 2.2).
methoDoLogicAL consiDerAtions
study population and selection bias
We prospectively studied a large cohort of consecutive patients with a recent TIA or minor 
ischemic stroke corresponding with grade 3 or less on the modified Rankin scale.4 We excluded 
patients with a carotid artery stenosis who were planned for carotid surgery. These patients 
were excluded because carotid artery stenosis is related to the presence of MES,5 diminished 
cerebral CO2-reactivity,
6 and altered flow velocities in the middle cerebral artery.7 Both TCD 
parameters and risk of recurrent events would be affected by the carotid surgery, which would 
make our results more difficult to interpret. We also excluded patients with mechanical heart 
valves, since in these patients MES occur frequently, and are thought to be gaseous, not solid.8 
It may seem that exclusion of these patients can lead to selection bias, but in these particular 
patients subgroup, the value of TCD was already clear. These subgroups were therefore not of 
interest. Our study was designed to explore the value of TCD in the rest of the stroke popula-
tion. We aimed for 800 patients, but inclusion was slower than expected. Therefore, only 598 
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patients were included, but we prolonged the duration for follow-up, which resulted in more 
outcome events and hence sufficient statistical power.
Although our proportion window failure of 18% matches that of other studies,9,10 it implies that 
our findings are not representative for the entire hospital population of patients with recent 
TIA or stroke. This kind of selection bias is unavoidable. Of the patients with successful TCD 
registration, only 4 were lost to follow-up.
Patients were included in the study from 1999 to 2002. Risk of recurrent vascular events has 
declined over the past 50 years.11 Risk of recurrent vascular events in patients with a TIA or 
ischemic stroke today is therefore very likely to be lower than 10 year ago at the time of our 
study period. The declined risk of recurrent vascular events can be attributed to a better treat-
ment of hypertension and hypercholesterolemia.11 In the past ten years the preventive effect 
of statins12 and antihypertensive drugs13 in patients with vascular disease has been sufficiently 
proven. The prevalence of these risk factors has not decreased, but treatment has improved. 
Patients with a TIA or ischemic stroke are currently more often treated with statins and antihy-
pertensive drugs according to current guidelines. More recently, the ESPRIT study showed that 
adding dipyridamole to aspirin for secondary prevention led to a further reduction of recurrent 
vascular events of 1% per year.14 It is not likely that my conclusions about the role of MES and 
flow velocity will be affected by these developments, because it concerns relative risk estimates. 
However, the calibration of our prediction model may be affected by the lower overall risk of 
recurrent vascular events, and it may have to be adapted before applying it to new populations.
tcD recordings
In our study, one experienced investigator carried out all the TCD registrations, and all audio-
tapes were analysed by the same investigator. This excludes interobserver variability.15 We did 
not assess intra-observer variability, but previous studies have shown that intra-observer vari-
ability regarding Doppler ultrasound measurements is reasonable.16,17 One investigator was 
involved in analysis of TCD registrations and in analysis of outcome events. In order to maintain 
blinded assessment the outcome events were anonimized.
Our results showed that window failure was related to bone thickness and bone density (Chap-
ter 2.2). Our definition of window failure was the failure to develop en envelop around the 
TCD signal when using the headband. One could argue that this is still subjective, but to our 
opinion, no clearer definition is present.
tcD validation
Confounding is present when a factor is associated with both the determinant and the out-
come. We have not performed any other tests to evaluate the cerebral circulation. There may 
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be unobserved confounding in our study. A stenosis of the middle cerebral artery (MCA) is 
such a potential confounder. Blood flow velocity is related to vessel diameter, it increases when 
the vessel diameter decreases. However, only one patient met the criteria for an MCA stenosis 
of more than 50%.18 Excluding this patient from the analysis did not change our results. It is 
therefore very unlikely that our results were influenced by the presence of an MCA stenosis.
Prognostic value
The identification of prognostic factors in a multivariable model is essentially not the same as 
prediction. These two terms can be confusing. When a factor is related to outcome events, and 
therefore occurs more often in patients with an outcome event than in patients without the 
outcome event, it means that this factor is a prognostic factor in patients. It does not mean, 
however, that one can estimate the individual risk of an outcome event more precisely. The 
estimation of individual risks in patients is called prediction. We have first investigated whether 
TCD parameters were prognostic factors (Chapter 3.2), and after that, we investigated whether 
these factors could contribute to the prediction of recurrent events by adding the TCD param-
eters to existing prediction models (Chapter 3.4).
Prediction
We validated 7 prediction models in our cohort of patients with a recent TA or ischemic stroke. 
Our cohort consisted of 598 patients, which may seem rather small to perform external valida-
tion of these prediction models. Nevertheless, the results showed clear distinction between 
population based models and models based in patients with a recent TIA or stroke (Chapter 
3.1).
We validated two-year risk using survival analysis which was not easy because of the cen-
soring. Censoring occurs when patients are withdrawn from survival analysis after a certain 
time point because they have either already reached the outcome event, or when the end of 
the follow-up period is reached. In our study some patients only had a few months follow-up 
because the end of the study period was reached. Of these patients it is unknown whether they 
would experience an outcome event in the near future or not. Thus, they do not contribute the 
same amount of information to the analysis as patients with long follow-up. Usually, external 
validation concerns diagnostic test, not prognostic tests.
The discrimination was calculated using the c-statistic and the Net Reclassification Index (NRI). 
The c-statistic is derived from the sensitivity and specificity of a model, the NRI calculates the 
proportion of patients who were reclassified correctly after adding a parameter to the predic-
tion model versus the proportion of patients who were reclassified incorrectly. The c-statistic 
was adjusted for censoring, the NRI was not adjusted for censoring. The statistical analysis using 
the NRI is new and has not been used in survival analysis before. It would be logical to adjust for 
duration of follow-up, or at least stratify for this duration since risk of recurrent events increases 
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with time of exposure. This method has however not yet been developed. This is a methodologi-
cal restriction which cannot be overcome for now. However, in our study, the c-statistic as well 
as the NRI showed improvement of the ABCD2 prediction model when both the fifth quintile 
of MFV and PI-MFV ratio were added (Chapter 3.4). Moreover, as the comparison of NRI’s was 
based on the same dataset, most of the bias because of censoring would be canceled out.
Finally, we used calibration graphs with only 5 groups because of the low number of patients 
and therefore outcome events. Fortunately, only few prediction models showed outliers.
cLinicAL imPLicAtions AnD Future reseArch
Diagnostic value of transcranial Doppler ultrasonography
Mean Flow velocity
The finding that MFV is related to several vascular risk factors such as age, male sex,diabetes, 
cholesterol, and hypertension is not surprising (Chapter 2.1). These vascular risk factors lead to 
arterial stiffness19 and MFV increases with narrowing of the arterial vessels. Thus, MFV can be 
regarded as a general measure of systemic disease, atherosclerosis. In this thesis I have focused 
on one measurement, but it would be very interesting to investigate whether MFV changes 
with aggressive treatment of the vascular risk factors such as diabetes, hypercholesterolemia, 
and hypertension, as well as cessation of smoking. Future research could include serial TCD 
investigation to answer that question.
Cerebrovascular CO2-reactivity
In my study, cerebrovascular CO2-reactivity was related to cholesterol: the cerebrovascular CO2-
reactivity decreased when total serum cholesterol increased chapter 2.1). This is in accordance 
with results of studies in the healthy population.20 In the healthy population CO2-reactivity is 
related to white matter lesions,21,22 but this could not be reproduced in our patients with a TIA 
or minor stroke. The cerebrovascular CO2-reactivity was not related to the other vascular risk 
factors in this study. Silvestrini et al. however, showed that smoking has a short-term, direct 
effect on the cerebrovascular CO2-reactivity.
23 This provides suggestions for future research: it 
would be interesting to investigate the cerebrovascular CO2-reactivity before and after cessa-
tion of smoking.
Micro-embolic signals
The occurrence of MES can clearly discriminate between non-lacunar and lacunar stroke, since 
MES are not present in lacunar stroke. These findings apply only to the acute phase of stroke. 
The sensitivity of MES is low, which indicates that MES are not a frequent finding in stroke 
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patients without carotid artery disease. Specificity, on the contrary, is very high which means 
that when MES are present, one may safely assume that the stroke was non-lacunar. Usually, 
non-lacunar stroke is a clinical diagnosis, but in some patients without a visible infarction on the 
first CT-scan of the head cortical symptoms may be mild or transient and therefore overlooked. 
The occurrence of MES is higher in the acute phase of stroke24 then in a later phase of stroke.25
For screening of a PCSE, the presence of MES is not discriminatory (Chapter 2.3). Both sen-
sitivity and specificity are not high. This has not been investigated in a cohort of unselected 
stroke patients before. In future, very early MES detection in a population of unselected stroke 
patients could possibly answer that question.
For MES detection, patients have to wear a metal headband for at least 30 minutes. This is 
very inconvenient, especially for older patients in the early phase of stroke. Some newer TCD 
systems do not work with these unfriendly headbands, but with recording systems where the 
transducer is held in place on a glasses frame.26 With these systems patients can be ambula-
tory and even 24 hr registrations can be possible. Especially in patients with an asymptomatic 
carotid artery stenosis longer duration of TCD registration increases the probability of finding 
MES.27
Prognostic value of transcranial Doppler ultrasonography
Mean Flow velocity
Mean flow velocity is a prognostic factor for recurrent vascular events after TIA or minor ischemic 
stroke (Chapter 3.2). In the general population this is a linear relationship.28 In our study, this 
increased risk of recurrent vascular events only occurred in patients in the highest quintile of 
MFV. The PI-MFV ratio also showed an increased risk of recurrent vascular events implying that 
high peripheral vascular resistance is an important factor in the occurrence of vascular events. 
There are strong indications that PI is related to small vessel disease,29 and MFV is related to the 
vessel diameter. It is therefore not surprising that the PI-MFV ratio shows an increased risk of 
recurrent vascular events. To further evaluate this new factor TC-Duplex would be more helpful 
since it can also measure vessel diameter as well as flow velocities in the major cerebral arteries. 
These measurements should preferably be performed in the acute phase of stroke.
Cerebral CO2 reactivity
The prognostic value of cerebrovascular CO2-reactivity has not yet been elucidated. In our 
study in patients without a carotid artery stenosis, the cerebrovascular CO2-reactivity was not 
related to recurrent major vascular events or recurrent stroke (Chapter 3.2). We investigated 
patients without a carotid artery stenosis since the presence of MES has already been exten-
sively investigated in patients with a carotid artery stenosis; in these patients, cerebrovascular 
CO2-reactivity is a prognostic factor for recurrent stroke, both in symptomatic patients,
30-33 and 
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asymptomatic patients.30,34 Molina et al. have found that in the normal population an impaired 
cerebrovascular CO2-reactivity was a marker for first-ever lacunar infarction.
35 In our study, we 
have not made the distinction between lacunar infarction and non-lacunar infarction in our 
outcome events. This may be promising to investigate in future.
Micro-Embolic Signals
The occurrence of MES in our population was low, but when MES were present, this was a 
strong prognostic factor for recurrent vascular outcome events (Chapter 3.3). We excluded 
patients with a carotid artery stenosis who were planned for carotid surgery. These patients 
were excluded because carotid artery stenosis is related to the presence of MES,5 and in these 
patients risk of recurrent events would be affected by the carotid surgery, as mentioned before. 
In patients with a carotid artery stenosis presence of MES is higher, varying from 6% in patients 
with an asymptomatic carotid artery stenosis36 to 45% in patients with a symptomatic carotid 
artery stenosis.37 It would be interesting to evaluate the presence of MES in patients with mild 
carotid artery stenosis (30 to 70%). In these patients, the prognostic value of MES still has to 
be determined to evaluate if MES detection is worthwhile in these patients. In our study, we 
performed off-line analysis of audio tapes to detect MES. This is time consuming, especially 
when prevalence of MES is low. Newer automatic detection show better classification of signals 
into MES or artefacts and seem therefore promising.38
Prediction
External validation of several population based models and stroke based models showed that 
the ABCD2 prediction model performed best; both calibration and discrimination were fairly 
good (Chapter 3.1). Adding MFV and PI-MFV ratio improved this prediction model (Chapter 3.4). 
Our study was one of the first to externally validate this model; ours is the only study which has 
looked at improvement of this model by adding TCD parameters. Adding the presence of brain 
infarction in CT improves the ABCD2 model, which resulted in the ABCD2I model.39 It would be 
interesting to evaluate the improvement of the ABCD2 model with both TCD parameters and 
the presence of brain infarction on CT for the long-term prediction of recurrent vascular events 
after stroke.
Final conclusion
Our results indicate that TCD is a promising technology in patients with a recent TIA or ischemic 
stroke, especially MES detection and measurement of flow velocities. MES detection, however, 
seems more promising in the early after stroke onset since MES are more often present in the 
acute phase. 24 The prognostic value of MES in the acute phase of stroke for the long-term 
prediction of recurrent stroke or other vascular events has not been elucidated and should be 
studied further.
General discussion 125
Most importantly, MFV measured in the middle cerebral artery is an independent prognostic 
factor for recurrent vascular events such as ischemic stroke, non-fatal myocardial infarction and 
vascular death, as well as the combined PI-MFV ratio. The MFV improves the prediction of recur-
rent vascular events, when added to clinical prognostic variables. This finding addresses one 
major question of this thesis. The challenge for the future is to further improve the diagnostic 
and prognostic impact of transcranial ultrasound, by using more sophisticated techniques and 
at the same time improving patient-friendliness. 
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Stroke is the third leading cause of death in developed countries, after heart disease and 
cancer. Most strokes are ischemic and caused by occlusion of a cerebral artery. This leads to 
dysfunction and eventually death of brain tissue through lack of oxygen. This may result in 
typical symptoms such as unilateral weakness, language disturbances, unilateral sensory 
disturbances, hemianopia, ataxia, or impaired speech. In many patients, cerebral ischemia is 
only transient and does not result in persistent symptoms and disability. When disability is 
persistent, the event is called an ischemic stroke. In the acute phase of tissue dysfunction, at 
most 25% of the patients can be treated with thrombolytic agents, but even when patients can 
be treated, treatment is not always successful. Secondary prevention is therefore one of the 
main objectives of stroke management. Risk of recurrent stroke is approximately 9-16% annu-
ally after ischemic stroke. Intensive secondary prevention by use of antiplatelet medication and 
treatment of high blood pressure and high cholesterol has reduced the annual risk of recurrent 
events to approximately 4.5%. Well-known risk factors for stroke or other major vascular events 
such as myocardial infarction or vascular death are age, male sex, hypertension, diabetes, and 
smoking. Unfortunately, it is still difficult to discriminate between patients with a high risk of 
recurrent stroke and patients with a low risk of recurrent stroke.
Transcranial Doppler ultrasonography, the main topic of this thesis, offers noninvasive infor-
mation on the large cerebral arteries. Low frequency (2 MHz) ultrasound can pass through 
the bone at the level of the temporal window, which is located just above the ear where the 
temporal bone is the thinnest. With this technique, mean flow velocity (MFV), peak systolic 
flow velocity (PSV), and enddiastolic flow velocity (EDV) in the middle cerebral artery can be 
measured. With these parameters, the pulsatility index (PI) can be calculated: PI=(PSV-EDV)/
MFV. The PI is thought to reflect the peripheral resistance in a large artery. Through inhalation 
of 5% carbon dioxide cerebral CO2-reactivity can be measured, a functional TCD test which is 
thought to reflect elasticity of the smaller cerebral blood vessels. Micro-embolic signals (MES) 
can be measured during a continuous TCD registration. 
To evaluate the clinical value of these TCD tests, we have conducted the Rotterdam TCD study. 
In this study we have performed TCD registration in 598 consecutive patients with a recent TIA 
or minor ischemic stroke. We measured flow velocities, cerebral CO2-reactivity, and presence of 
MES during a 30 minute registration.  The research questions were:
1. Can TCD be of diagnostic value in detetecting the presence of a potential cardiac source of 
embolism and the presence of small vessel disease in patients with a TIA or minor ischemic 
stroke?
2. Is it possible to identify patients with a high risk of recurrent vascular events after TIA or 
minor ischemic stroke by means of TCD investigation? 
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To answer these questions we have firstly evaluated the diagnostic value of TCD in chapter 
2. chapter 2.1 describes the relationship between TCD parameters and vascular risk factors. 
Blood flow velocity in the MCA decreases with age, and is lower in men than in women. Blood 
flow velocity in the MCA increases with total serum cholesterol, and is increased in diabetics 
compared to non-diabetics. Cerebrovascular CO2-reactivity is lower in hypertensive patients 
and decreases with increasing total serum cholesterol. Our results indicate that the cerebral 
flow velocity in the MCA is influenced by multiple interacting factors.
In chapter 2.2 we show the relationship between skull thickness, bone density, and window 
failure. Window failure (WF) means that no adequate TCD signal can be obtained. Window 
failure is more common in older women. We conclude that both thickness and density of the 
temporal bone are related to the presence of WF, but that skull density does not independently 
predict WF. Absence of WF can be predicted accurately in nearly all patients with ischemic 
stroke or TIA by means of three simple parameters: skull thickness, age and gender.
In chapter 2.3 we review studies on the diagnostic value of TCD in patients with a TIA or minor 
ischemic stroke. We give an overview of studies which evaluated whether the presence of MES 
can distinguish between patients with a lacunar infarction (small vessel disease) and patients 
with a cortical infarction (non-small vessel disease). We also give an overview of studies which 
evaluated whether TCD can be helpful in detection of a potential cardiac source of embolism 
(PCSE). We have combined these results with our own findings. Our results indicate that TCD 
could be a useful test to distinguish non-small vessel disease from small vessel disease. For a 
PCSE, TCD alone does not seem able to adequately distinguish between the presence and the 
absence of a PCSE.
In chapter 3 we describe the prognostic value of TCD. In chapter 3.1 we validate predictions 
from seven well-known prediction models in our own cohort of patients. Prediction models 
derived from stroke cohorts perform better than population-based prediction models in 
prediction of 2-year risk of recurrent vascular events. Of these prediction models, the ABCD2 
prediction model seems to be most adequate and most easily applicable in clinical practice. 
In chapter 3.2 we investigate the prognostic value of the individual TCD parameters. Because 
of the expected interaction between MFV and PI, we created a new parameter, the PI-MFV ratio 
that MFV and PI-MFV ratio, calculated as PI/MFV*100. MFV and PI-MFV ratio, measured in the 
MCA by TCD, are independent risk factors for recurrent stroke. Interestingly, MFV and PI-MFV 
ratio were also associated with the occurrence of major vascular events (combined outcome 
measure “stroke, MI, and vascular death”). This suggests that the MFV and PI-MFV ratio reflect 
not only the condition of the major cerebral blood vessels, but also that of coronary and periph-
eral arteries.
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chapter 3.3 shows that MES are not often present in patients with a recent TIA or ischemic 
stroke without a carotid artery stenosis, only in 4%. However, MES do indicate increased risk for 
recurrent stroke in these patients.
In chapter 3.4 we show that adding MFV and MES to the ABCD2 prediction model improves 
calibration as well as discrimination of this model. Calibration measures how closely predicted 
outcomes agree with actual outcomes. Discrimination refers to the ability to distinguish 
between patients who will have an outcome event and those who will not. This chapter shows 
that MES and a MFV>60.5 cm/s in the MCA are independent prognostic factors for long term 
prognosis in patients with a recent TIA or minor ischemic stroke when added to the ABCD2 pre-
diction model. Moreover, adding these two factors to the ABCD2 prediction model improves 
calibration as well as discrimination.
In chapter 4 I reflect on the main findings in the context of current knowledge and give sug-
gestions for future research.
On the basis of our studies and current literature we conclude that TCD could be a useful 
test to distinguish non-small vessel disease from small vessel disease, but not for the detection 
of a PCSE. TCD parameters such as MFV and cerebral CO2-reactivity are related to vascular risk 
factors such as age, gender, diabetes, cholesterol, and hypertension. This implies that in future 
studies of TCD parameters as prognostic or diagnostic factors in patients with a TIA or stroke, 
ultrasound findings will have to be adjusted for these vascular risk factors.
The presence of MES is a prognostic factor in patients with a recent TIA or ischemic stroke, 
even in patients without a carotid artery stenosis. Detection of MES is, however, time-consum-
ing; occurrence of MES is low in patients without a carotid artery stenosis.  MFV and PI-MFV ratio 
seem to reflect atherosclerosis. These parameters are prognostic factors after a TIA or minor 
ischemic stroke. Adding MES and MFV to the ABCD2 prediction model improves the calibration 
and discrimination of this model. These findings will have to be further investigated in larger 
studies.
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Een beroerte is de derde doodsoorzaak in Westerse landen na hartziekten en kanker. Het 
merendeel van de beroertes wordt gevormd door herseninfarcten. Hierbij  wordt een bloedvat 
in de hersenen afgesloten. Dit leidt tot zuurstofgebrek en sterfte van hersencellen waardoor er 
functiestoornissen van de hersenen ontstaan. Deze functiestoornissen uiten zich onder andere 
als éénzijdig krachtsverlies, spraakstoornissen, coördinatiestoornissen, gezichtsvelduitval of 
een taalstoornis. Soms verdwijnen de verschijnselen weer en spreekt men achteraf van een 
tijdelijke ischemische aanval oftewel transient ischemic attack: een TIA. Als er blijvende schade 
optreedt gaat het om een herseninfarct. In de acute fase kan momenteel hooguit 25% van de 
patiënten behandeld worden met aggressieve bloedverdunners (trombolytica), en deze behan-
deling is ook niet altijd succesvol. Om die reden  is preventie van toekomstige herseninfarcten 
of andere uitingen van hart- en vaatziekten bij patiënten met TIA’s of herseninfarcten uitermate 
belangrijk.  Het risico op nieuwe beroertes of andere uitingen van hart- en vaatziektes bij deze 
patiënten is ongeveer 9 tot 16% per jaar. Dit risico wordt teruggebracht tot ongeveer 4.5% 
na starten van intensieve medicameneuze preventie zoals bloedplaatjes-aggregatieremmers, 
antihypertensiva en statines. De belangrijke risicofactoren zijn hoge leeftijd, mannelijk 
geslacht, hoge bloeddruk, roken en diabetes mellitus. Helaas is het nog steeds niet mogelijk 
om te voorspellen wie wel of wie juist opnieuw een herseninfarct of andere uiting van hart- en 
vaatziekten zal krijgen. 
Met transcranieel Doppler ultrageluid (TCD) kan men  non-invasief informatie krijgen over de 
grote bloedvaten in de hersenen. Net boven het oor is het “temporale bot window” oftewel 
“temporal bone window” gelokaliseerd. Hier is het bot iets dunner waardoor ultrageluid (2 
MHz) door het bot heen dringt. Hiermee kan in de arteria cerebri media de gemiddelde snel-
heid (MFV), de pieksystolische snelheid (PSV) en de einddiastolische snelheid (EDV) van het 
bloed worden gemeten. Aan de hand van deze waarden kan de pulsatility index (PI) worden 
berekend: PI=(PSV-EDV)/MFV. Dit is een maat voor de perifere weerstand in een slagader. 
Met toediening van kooldioxide kan de cerebrale CO2-reacitiviteit worden gemeten, een test 
waarmee de elasticiteit van de  kleine bloedvaten in de hersenen wordt gemeten. Als derde 
kan tijdens een langdurige registratie het aantal micro-embolische signalen (MES) worden 
gemeten. Dit zijn luidere signalen die suggereren dat er een partikel in de bloedbaan passeert, 
dit kan onder andere een luchtbelletje, of een stolsel zijn.
Om meer inzicht te krijgen in de klinische waarde van deze tests hebben we de Rotterdam 
TCD Studie uitgevoerd. Hierbij hebben we bij 598 opeenvolgende patiënten met een TIA of 
een licht herseninfarct TCD metingen gedaan waarbij, indien mogelijk, de snelheden in de 
arteria cerebri media en de cerebrale CO2-reactiviteit gemeten, en de aanwezigheid van MES 
geregistreerd gedurende een half uur. In deze studie stonden twee vraagstellingen centraal:
1. Heeft TCD diagnostische waarde in het detecteren van een cardiale emboliebron en het 
detecteren van subtype van ee herseninfarct bij patiënten met een TIA of licht herseninfarct?
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2. Is het mogelijk om patiënten met een hoog risico op nieuwe vasculaire events (gebeurte-
nissen) na een TIA of licht herseninfarct te identificeren met TCD? Zo ja, kan TCD huidige 
predictiemodellen verbeteren?
Om deze vragen te kunnen beantwoorden hebben we in hoofdstuk 2 allereerst gekeken naar 
de diagnostisch waarde van TCD. hoofdstuk 2.1 beschrijft allereerst welke risicofactoren van 
invloed zijn op de TCD metingen. Gebleken is dat oudere leeftijd en het mannelijk geslacht 
gerelateerd zijn aan lagere snelheden in de arteria cerebri media. De aanwezigheid van diabe-
tes en de aanwezigheid van hypercholesterolemie waren juist gerelateerd aan hogere snelhe-
den in de arteria cerebri media. De cerebrale CO2-reactiviteit is gemiddeld lager bij patiënten 
met hypertensie of hypercholesterolemie. Dit betekent dat de TCD parameters door multipele 
factoren beinvloed worden en dat hier voor gecorrigeerd moet worden bij analyses naar de 
diagnostische of prognostische waarde van deze TCD parameters.
In hoofdstuk 2.2 laten we de relatie zien tussen schedeldikte, densiteit van het schedelbot en 
de kans op window failure. Window failure betekent dat er geen goed TCD signaal verkregen 
kan worden. Dit treedt vaker op bij met name oudere vrouwen. In dit hoofdstuk tonen we aan 
dat zowel de schedeldikte als densiteit ook gerelateerd zijn aan het optreden van window 
failure. Wij hebben ook een predictiemodel ontwikkeld met als variabelen leeftijd, geslacht, 
schedeldikte en schedeldensiteit, waarmee vrij accuraat kan worden voorspeld of er sprake zal 
zijn van window failure of niet.
In hoofdstuk 2.3 wordt gekeken naar de diagnostische waarde van TCD bij patiënten met een 
TIA of een licht herseninfarct. Wij geven allereerst een overzicht van studies die onderzoek heb-
ben gedaan of de aanwezigheid van MES kan differentiëren tussen patiënten met een lacunair 
of corticaal herseninfarct. Hierna hebben we ook onderzocht of de aanwezigheid van MES een 
cardiale emboliebron kan detecteren. Deze bevindingen hebben we gecombineerd met onze 
eigen resultaten. Onze resultaten laten zien dat TCD nuttig kan zijn om onderscheid te maken 
tussen een corticaal en een lacunair infarct. TCD heeft echter geen diagnostische waarde in het 
detecteren van een cardiale emboliebron.
In hoofdstuk 3 beschrijven we in op de prognostische waarde van TCD. Allereerst hebben we 
in hoofdstuk 3.1 zeven gerenommeerde predictiemodellen met elkaar vergeleken door ze te 
valideren op onze eigen dataset. Hierbij kwam naar voren dat predictiemodellen die afgeleid 
zijn van grote groepen patiënten met een eerdere TIA of herseninfarct beter het 2-jaars risico 
op nieuwe vasculaire events voorspellen dan predictiemodellen die op de algemene populatie 
gebaseerd zijn. Van deze predictiemodellen is het ABCD2 predictiemodel vrij betrouwbaar en 
makkelijk te hanteren aangezien er weinig variabelen gebruikt worden in dit predictiemodel.
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hoofdstuk 3.2 toont aan dat een hoge snelheid in de arteria cerebri media (meer dan 60.5 cm/
seconde) een verhoogde kans geeft op zowel nieuwe beroertes als nieuwe vasculaire events. 
Omdat er ook een interactie werd verwacht tussen de PI en de MFV hebben we een nieuwe 
factor gecreëerd: de PI-MFV ratio (berekend als PI/MFV*100). Deze interactiefactor heeft een 
lineaire relatie met het risico op nieuwe beroertes en nieuwe vasculaire events. MFV en de 
PI-MFV ratio zijn prognostische factoren na een TIA of een licht herseninfarct, onafhankelijk 
van andere risicofactoren. Mogelijk reflecteren deze parameters niet alleen de mate van athe-
rosclerose in de hersenslagaders, maar ook in de rest van het cardiovasculaire systeem.
In hoofdstuk 3.3 hebben we de prognostische waarde van MES onderzocht bij patiënten 
zonder een carotisstenose. Deze MES komen slechts bij 4% van de patiënten met een TIA of 
licht herseninfarct zonder carotisstenose in onze studie voor. Bij aanwezigheid van deze MES is 
er echter een verhoogd risico op nieuwe beroertes.
In hoofdstuk 3.4 onderzoeken we of toevoeging van TCD parameters aan het ABCD2 predic-
tiemodel voorspelling van nieuwe vasculaire events verbetert. Hierbij hebben we gekeken 
naar de calibratie en de discriminatie. De calibratie meet hoe goed voorspelde vasculaire 
events overeenkomen met daadwerkelijk opgetreden vasculaire events. Discriminatie verwijst 
naar het vermogen om onderscheid te kunnen maken tussen patiënten met een hoog risico 
op nieuwe vasculaire events en patiënten met een laag risico op nieuwe events. Toevoeging 
van de aanwezigheid van MES en MFV > 60.5 cm/seconde verbetert zowel de calibratie als de 
discriminatie van het ABCD2 predictiemodel.
In hoofdstuk 4 worden de belangrijkste bevindingen in de context van de bestaande literatuur 
besproken en worden suggesties voor verder onderzoek gedaan.
Op basis van onze studies en de literatuur concluderen wij dat TCD geen waarde heeft bij 
het onderscheid maken tussen een corticaal of een lacunair infarct. Ook helpt TCD niet bij het 
detecteren van een cardiale emboliebron. Wel zien wij een duidelijke relatie tussen cardio-
vasculaire risicofactoren en TCD parameters zoals de MFV en de cerebrale CO2-reactiviteit. Dit 
betekent dat bij onderzoeken naar deze parameters altijd voor cardiovasculaire risicofactoren 
gecorrigeerd moet worden. 
De aanwezigheid van MES is prognostisch van belang, ook voor patiënten zonder carotisste-
nose. Het detecteren van MES is echter nog tijdrovend en MES komen weinig voor bij patiënten 
zonder carotisstenose. De MFV en de PI-MFV lijken een mate van atherosclerose te weerspie-
gelen; deze parameters hebben naast de eenvoudige klinische parameters een duidelijke 
prognostische waarde na een TIA of licht herseninfarct. Wanneer MFV and MES toegevoegd 
worden aan het ABCD2 predictiemodel verbeteren zowel de calibratie als de discriminatie 
van dit model. Deze bevindingen zullen echter in een groter onderzoek gerepliceerd moeten 
worden.  
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TIA Transient ischemic attack
MES Micro-embolic signals
TCD Transcranial Doppler ultrasonography
MFV Mean flow velocity
PSV Peak systolic flow velocity
EDV Enddiastolic flow velocity
PI Pulsatility index
PCSE Potential cardiac source of embolism
MCA Middle cerebral artery
CT Computed tomography
ROI Region of interest
WF Window failure
AF Atrial fibrillation
PI/MFV ratio 100xPI/MFV
NRI Net reclassification index
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voor het bellen van patiënten en het invoeren van alle data. Zonder jullie fanatieke gebel had-
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graag bedanken voor de gezelligheid:  Beste Sonia, Rinske, en de rest: het was leuk!  Mary-Lou 
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